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Abstract 
 
It has been established that a combination of Pd2dba3 and XPhos in a ratio of 
2:1 is an efficient precatalyst for the Negishi cross-coupling reaction between 
the organozinc reagent 4 derived from iodoalanine and aromatic halides 
(Scheme 2.9). The yields from these reactions show improvement of 5-30 % 
on those previously obtained using SPhos. 
 
 
Scheme 2.9: Negishi cross-coupling reaction of organozinc reagent 4 and 
aryl iodides 
 
The use of Pd2dba3 and XPhos in the challenging cross-coupling reactions of 
organozinc reagent 4 and electron-rich halothiophenes has also had some 
success. Specifically reactions between thiophene halides with 4 have been 
achieved in yields of 50-65% compared to the low yields previously obtained 
using alternative phosphine ligands.  
This thesis describes the development and successful scaling of the side 
chain, C-H activation and iodination reaction of alanine up to a 10 mmol 
scale, giving large scale reproducible results that were previously 
unobtainable (Scheme 3.24).  
xi 
 
 
Scheme 3.24: Side chain iodination of alanine. 
 
Cleavage of the 8-aminoquinoline group has successfully been achieved to 
afford the methyl ester (Scheme 3.81), from which phenylalanine derivatives 
can be synthesised using Negishi cross-coupling conditions. 
 
Scheme 3.81: Removal of the 8-aminoquinoline group using conditions 
employed by Chatani and co-workers. 
Lactic acid derivative 78 has successfully undergone a C-H activation and 
acetoxylation reaction to give the glyceric acid derivative 86 in excellent 
yield to give the first reported example of catalytic C-H activation on lactic 
acid derivatives (Scheme 3.68). 
 
 
Scheme 3.68: Acetoxylation of lactic acid derivative 78.
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1. Synthesis of α-Amino Acids 
 
There has been much, well reviewed development in the synthesis of 
enantiopure α-amino acids; however it still poses an ongoing challenge 
within the field of organic chemistry. There are many general methods for 
synthesising enantiopure α-amino acids utilising chiral auxiliaries, chiral 
catalysts and the chiral pool.1,2 
The first reported synthesis of an amino acid was the Strecker reaction which 
was discovered in 1850 on the formation of racemic alanine from 
acetaldehyde (Scheme 1.1).3 The reaction proceeds by condensation of the 
aldehyde or ketone with ammonia to give an imine which then undergoes 
nucleophilic attack from a cyanide ion forming the α-amino nitrile. This can 
then be hydrolysed to give the desired amino acid product. More recently 
conditions have been developed allowing for the reaction to be carried out 
both catalytically and asymmetrically on a wide range of substrates with 
chirality being induced by the use of chiral catalysts, chiral auxiliaries or by 
chiral resolution of the racemic product.4 
 
 
 
 
 
Scheme 1.1: Strecker synthesis of amino acids. 
 
 
A second efficient route to enantiomerically pure amino acids is the catalytic 
asymmetric hydrogenation of the corresponding dehydroamino acids. This 
approach was originally pioneered by Knowles using α-acylaminoacrylic 
acids as substrates with chiral rhodium bisphosphine catalysts, for which he 
was awarded a part-share in the Nobel Prize in 2001 (Scheme 1.2). 5 
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Scheme 1.2: Asymmetric hydrogenation of α-acylaminoacrylic acids. 
 
 
A third approach for the synthesis of enantiopure amino acids is the 
electrophilic azidation of chiral imides, an example of which was developed 
by Evans and co-workers (Scheme 1.3). This method employs a chiral 
auxiliary to promote the diastereoselective formation of α–azido 
carboximides.6     
 
 
Scheme 1.3: Azidation of chiral imides by Evans and co-workers. 
 
A final route to the synthesis of amino acids is use of glycine α-anion 
equivalents, an example of which is the benzophenone imine 1 of a glycine 
alkyl ester (Figure 1.1). Following deprotonation the α-anion can undergo 
alkylation providing a simple method of accessing unnatural amino acids. In 
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this case the stereochemistry can be controlled by use of a chiral phase 
transfer catalyst such as compound 2.7 
 
 
Figure 1.1: Glycine α-anion equivalent and chiral phase transfer catalyst. 
 
A disadvantage of the methods discussed is the requirement for chirality to 
be induced in the resulting products. A simpler means of achieving the 
synthesis of enantiopure compounds would be to use naturally occurring 
amino acid starting materials from the chiral pool, allowing the already 
defined stereocentre to be carried through to the product. One way to 
achieve this is through the use of organometallic reagents derived from 
natural amino acids (Scheme 1.4). 
 
 
 
Scheme 1.4: Organometallic reagent derived from natural amino acids 
 
This thesis will focus on the formation of amino acid derived organometallic 
reagents for the synthesis of unnatural enantioenriched amino acids. 
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2. Development of Negishi Cross-Coupling Conditions   
 
2.1 Introduction 
2.1.1 Synthesis of Organozinc Reagents  
Organozinc reagents can be made by two possible methods. The first uses a 
transmetallation reaction of an organometallic reagent such as a Grignard 
reagent, with a zinc halide. Nonetheless, owing to the Grignard reagent’s 
relatively low functional group tolerance it has limited applicability. The 
second more preferable method is the direct insertion of elemental zinc into a 
carbon-halogen bond (Scheme 2.1). This was inadvertently discovered by 
Frankland in 1849 when the reaction between ethyl iodide and zinc metal 
produced diethylzinc.8  
 
Scheme 2.1: Formation of diethylzinc by Frankland and co-workers. 
Formation of an organozinc reagent can be difficult if the zinc is not first 
activated. This can be attributed to two main causes, the first being an outer 
oxide layer that is formed on the zinc on exposure to air. The second factor 
that can contribute to low reactivity of the zinc reagent is the particle size. 
Smaller particles have a larger surface area to mass ratio which allows more 
effective insertion of the zinc into the carbon-halogen bond. 
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There are a number of techniques available for activating zinc such as 
washing with aqueous HCl, sonication and using a Zn-Cu couple.9 A method 
employed by the Knochel group is the treatment of zinc powder with 
catalytic 1,2-dibromoethane followed by trimethylsilyl chloride in THF.10 
This has been subsequently modified by the Jackson group who established 
that trimethylsilyl chloride by itself in DMF produced effective conditions 
for the activation of zinc powder.11  
An alternative method now routinely used in the Jackson group has been 
developed by Huo and co-workers.12 This involves the use of catalytic iodine 
in DMF with zinc powder and works by small areas of exposed zinc metal 
on the surface reacting with the iodine in solution and forming zinc iodide. 
The zinc iodide goes into solution leaving a larger exposed surface area of 
zinc that can then insert into the desired carbon-halogen bond.   
The high functionality tolerance of organozinc reagents does have a 
disadvantage in that they are relatively unreactive towards standard 
electrophiles in comparison with alternative organometallic species. This can 
be surmounted by the addition of a catalyst to the reaction which allows the 
organozinc reagents to undergo transmetallation. 
2.1.2 Palladium Catalysed Negishi Cross-coupling 
In 1977 the first organozinc cross-coupling was reported by Negishi and co-
workers, who found that the reaction of phenylzinc chloride with 4-
iodoanisole in the presence of either 5 mol% Ni(PPh3)4 or 5 mol% 
Pd(PPh3)2Cl2 gave the biaryl 3 in 85% and 87% respectively (Scheme 2.2).13 
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Scheme 2.2: First organozinc cross-coupling. 
 
Continuing from this, much research has been undertaken to further develop 
the Negishi cross-coupling reaction. The methodology has been extended to 
include organozinc reagents derived from sp2, sp3 and secondary carbon-
halogen bonds.14,15  
2.1.3 Mechanism 
It is generally agreed that the Negishi cross-coupling reaction proceeds via 
three main steps; oxidative addition whereby the palladium inserts into the 
carbon–halogen bond, transmetallation where an alkyl group is transferred 
from the organozinc reagent onto the palladium centre, and reductive 
elimination to form the desired cross-coupled product. More recently 
however, DFT calculations undertaken by Wu and co-workers have 
suggested that there is a second transmetallation which accounts for the 
formation of homo-coupled and dehalogenation products as sometimes 
observed (Figure 2.1).16 
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Figure 2.1: Mechanism for Negishi cross-coupling reactions. 
2.1.4 Phosphine Ligands 
Phosphine ligands were initially used as a way of solubilising and stabilising 
the palladium catalyst, however they have recently been developed to also 
increase the activity of the catalyst. Ligands can moderate both the steric and 
electronic environment surrounding the palladium centre. There are a large 
range of ligands that have been used in palladium catalysis. Electron rich, 
sterically crowded biaryl phosphine ligands developed by the Buchwald 
group17 are some of the most commonly used as they have been found to 
produce more active catalysts in combination with a palladium source in a 
number of reactions (Figure 2.2).18,19  
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Figure 2.2: Biaryl phosphine ligands developed by Buchwald and co-
workers. 
It is thought that the high activity of these phosphine ligands could be due to 
the enhancement of the oxidative addition step of the catalytic cycle owing to 
the high electron density on the ligand, which can be transferred to the 
palladium. In addition to this, it is possible that the rate of the reductive 
elimination step is improved by the increased steric bulk of the ligand.  Due 
to this improved reactivity of the phosphine ligands, it means cross-
couplings can be undertaken more effectively with lower loadings of 
palladium.  
2.1.5 Jackson Group Development of Negish Cross-Coupling Conditions 
The Jackson group has undertaken extensive development of Negishi cross-
coupling conditions, primarily for the synthesis of phenylalanine derivatives. 
The coupling of iodoalanine derived organozinc reagent 4 with a range of 
aryl iodides has been optimised by varying the palladium source, the 
phosphine source and the method of zinc activation. 
The first generation cross-coupling conditions were reported in 1989, using a 
zinc-copper couple in DMA and benzene under ultrasound irradiation to 
form organozinc reagent 4.20 The preformed Pd/phosphine catalyst,    
PdCl2(P(o-tol3))2, was then added and 4 coupled with a range of aryl iodides 
(Scheme 2.3). Notably, the palladium source exists in oxidation state 2+ 
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although the active catalytic species which takes part in the Negishi catalytic 
cycle is palladium in oxidation state 0. This means the palladium source 
must first be reduced before the cross-coupling can occur. The yields of these 
products were variable (13-67%, based on iodoalanine) with ortho-substituted 
aromatics proving problematic. 
 
Scheme 2.3: The first generation of Jackson cross-coupling conditions. 
The second generation cross-coupling conditions were reported in 1992, 
altering not only the palladium source and the solvent but also the method 
of zinc activation (Scheme 2.4).21 The palladium source was changed from 
PdCl2(P(o-tol3))2 to Pd2(dba)3 obviating the need for the in situ reduction of 
the palladium to its active state. The phosphine ligand remained the same, 
but in this case was added separately in a 2:1 ratio to palladium. Zinc 
activation was achieved by a method developed by Knochel and coworkers 
using TMSCl and 1,2 dibromoethane.10 Using THF was found to give 
improved yields compared with those previously obtained (5 - 62%). 
Subsequent work in the group found that using DMF instead of THF, again 
improved the yields (40-70%). This has been explained by the increased 
stability of the organozinc reagent in the presence of DMF compared to 
THF.22 
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Scheme 2.4: The second generation of Jackson cross-coupling conditions. 
The third and final generation cross-coupling conditions arose through use 
of biaryl phophine ligands by Buchwald and co-workers (Figure 2.2) which 
have been found, in combination with a palladium source, to display high 
catalytic activity in a number of cross-coupling reactions.23,24  
This work encouraged the Jackson group to undertake their own 
investigations into the use of SPhos and other Buchwald ligands in the 
Negishi cross-coupling of the organozinc reagent 4 and aryl halides (Scheme 
2.5).18 Zinc activation was achieved using the method developed by Huo and 
co-workers, using iodine and zinc powder.12 The cross-coupling using a 
combination of Pd2(dba)3 with SPhos gave much improved yields, with the 
reaction proceeding at room temperature. It should also be noted that for 
some of the haloaromatics the catalyst loading could be dropped to 0.5 mol% 
and still produce comparable yields to the higher catalyst loading of 5 mol%. 
The lower yields observed tended to occur in couplings with either electron 
rich or ortho-substituted aromatics. 
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Scheme 2.5: The third generation of Jackson cross-coupling conditions. 
It was discovered that the reaction worked better with a 1:1 ratio of 
phosphine to palladium, as opposed to the usual requirement for a 2:1 ratio. 
This may be because SPhos is able to act as a bidentate ligand forming a 
highly active catalyst for the cross-coupling reaction (Figure 2.3). Mixed-
donor ligands, such as the P-O type ligands SPhos and RuPhos are 
hemilabile incorporating both hard donor sites (methoxy oxygen) and soft 
donor sites (arene carbons) in addition to the phosphorous centre. The 
stabilisation provided by the palladium-ligand species arises not only due to 
coordination of the phosphorus to palladium but also from extra stabilisation 
by either the ipso-carbon or the methoxy group. DFT calculations performed 
by Barder and co-workers have shown that the lowest energy conformation 
for the SPhos-palladium species changes when the palladium is oxidised 
from Pd(0) to Pd(II).25 When the palladium is in oxidation state 0, there is an 
unusual coordination between the ipso-carbon of the bottom phenyl ring and 
the palladium centre. However, after oxidative addition, stabilisation occurs 
due to the coordination of the lone pairs on the oxygen to the palladium (II) 
centre (Figure 2.3). There is other spectroscopic evidence for this 
coordination behaviour including metal-ligand crystal structures and 31P 
NMR data.23,25 
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Figure 2.3: Lowest energy conformations for the SPhos-palladium species. 
2.1.6 Negishi Cross-Coupling with Electron-Rich Electrophiles. 
Negishi cross-coupling reactions with electon-rich electrophiles still pose a 
challenge due to the reduced reactivity of the palladium species towards 
transmetallation, however there has been some recent progress made in the 
area. Yokoyama and co-workers have developed Negishi cross-coupling 
conditions for the synthesis of electron rich tryptophan derivatives, using 
organozinc reagent 5 and substituted 3-bromoindoles (Scheme 2.6).26 A series 
of Pd/phosphine combinations was applied to the coupling of 3-bromoindole 
to 5, including the Pd2(dba)3/SPhos system developed by Jackson and co-
workers which they reported to only give a moderate yield (43%) of the 
desired product.  It was found that using QPhos with Pd2(dba)3 in a 1:1 ratio 
of phosphine to palladium and an excess of organozinc reagent 5 gave a 
yield of 66%. These conditions were applied to the synthesis of a range of 
substituted tryptophan derivatives giving yields of 18-76%. 
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Scheme 2.6: Synthesis of tryptophan derivatives using Pd2(dba)3/QPhos 
catalysed Negishi cross-coupling reaction. 
 
Hedberg and co-workers have reported the cross-coupling of 2-
iodoimidazole 6 with iodoalanine derived organozinc reagent 7 (Scheme 
2.7).27 Initial attempts using a variety of palladium sources with 
triphenylphosphine and P(o-tol)3 gave low yields. However, on using XPhos 
with 3-fold excess of 7, a moderate yield of desired product 8 was obtained. 
14 
 
 
Scheme 2.7: Negishi cross-coupling of 2-iodoimidazole 6 with organozinc 
reagent 7. 
 
2.1.7 Negishi Cross-Coupling Reactions with Ortho-Substituted Aromatics 
Negishi cross-coupling reactions with ortho-substituted aromatics are more 
difficult due to steric hindrance. Recently Tuttle and co-workers have 
investigated Negishi cross-coupling reactions with organozinc reagent 4 and 
ortho-nitrobenzene derivatives which have traditionally been lower yielding 
(Scheme 2.8).28 The cross-coupling reaction of organozinc reagent 4 and ortho-
nitrobenzene was examined varying the phosphine ligands used (RuPhos, 
SPhos and XPhos) in a 2:1 ratio with Pd(OAc)2. Of these XPhos was found to 
be the superior ligand, giving the highest yield of 92% when using 1.5:1 ratio 
of the organozinc reagent to the haloaromatic coupling partner. It should be 
noted that the organozinc reagent is not the limiting reagent in work that has 
been undertaken by the Jackson group.18 The reaction conditions were 
applied to a range of substituted ortho-iodonitrobenzenes to give yields in 
the range of 41-77%. 
15 
 
 
Scheme 2.8: Cross-coupling reaction of organozinc reagent 4 and ortho-
nitrobenzene derivatives by Tuttle and co-workers. 
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2.2 Aims  
Work previously carried out in the Jackson group has shown that using 
SPhos and Pd2dba3 in the Negishi cross-coupling reaction between organzinc 
reagent 4 and arylhalides gives higher yields of the desired products than 
previously reported.18 However the yields of reactions with electron rich and 
ortho-substituted aromatics are still not ideal. 
The first aim of the project is to carry out Negishi cross-coupling reactions 
between organozinc reagent 4 and a range of aromatic iodides using 
phosphine ligands XPhos or QPhos under standard conditions, to compare 
the yield with those previously obtained using SPhos (Scheme 2.9). 
 
Scheme 2.9: Negishi cross-coupling of organozinc reagent 4 with aryl 
halides. 
A subsequent aim is to investigate the use of XPhos and QPhos in the cross-
coupling reaction between a variety of heterocycles and organozinc reagent 
4.  
17 
 
 
2.3 Results and Discussion 
2.3.1 Synthesis of Iodoalanine. 
Organozinc precursor protected iodoalanine 12 was synthesised following 
the literature procedure.18,29 L-Serine was converted to its methyl ester 
hydrochloride salt 9 by treatment with methanolic HCl (Scheme 2.10).29 Boc 
protection of compound 9 using (Boc)2O in water, with K2CO3 as the base, 
gave N-Boc-L-serine methyl ester 10 in a 75% crude yield over two steps. 
Tosylation of the alcohol 10, followed by a pseudo-Finkelstein reaction of the 
resulting tosylate 11 were carried out as reported by Jackson and co-
workers,18 yielding iodide 12 in a 24% overall yield from L-serine. 
 
 
Scheme 2.10: Synthesis of protected iodoalanine 
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2.3.2 Negishi Cross-Couplings using XPhos 
Tuttle and co-workers have  shown XPhos to be a superior ligand compared 
to SPhos and RuPhos in the Pd(OAc)2  catalysed cross-coupling of a range of 
substituted ortho-iodonitrobenzenes with an iodoalanine derived organozinc 
reagent (Scheme 2.8, page 15). The activity of the XPhos/Pd2dba3 catalyst was 
investigated modifying conditions previously developed in the Jackson 
group using SPhos. Thus iodoalanine derived organzinc reagent 4 was 
subjected to the ‘high loading’ cross-coupling conditions using Pd2dba3 (2.5 
mol%) and XPhos (5 mol%) with a range of aryl iodides (Scheme 2.9). 
 
 
Scheme 2.9: Negishi cross-coupling of organozinc reagent 4 with aryl 
halides. 
Table 2.1: High catalyst loading cross-coupling using XPhos. 
Entry ArI Product SPhosa XPhosb 
1c 
 
13 66 79 
2c 
 
14 53 84 
19 
 
Entry ArI Product SPhosa XPhosb 
3c 
 
15 51 83 
4 
 
16 79 84 
5 
 
17 66 69 
6 
 
18 71 75 
7 
 
19 76 78 
aYields obtained previously in the group.18 b Reaction carried out using 2.5 mol% Pd2dba3 
and 5 mol% XPhos. c Organozinc reagent removed from excess zinc.  
Initially the cross-coupling of 2-nitro iodobenzene with 3 was carried out to 
give a direct comparison of the result obtained by Tuttle and co-workers. The 
desired product 13 was obtained in 79% compared to the 95% reported by 
Tuttle and co-workers (Table 2.1, Entry 1). This difference in yield can partly 
be attributed to equivalents of organozinc reagent used. Whereas Tuttle and 
co-workers used an excess (1.5 eq) this reaction was carried out with 4 as the 
limiting reagent due to relative cost compared with its coupling partners. 
More interesting was the notable increase in yield on using XPhos compared 
to SPhos using the same conditions. With this result in hand, the reaction 
conditions were applied to the coupling of 4 with 3-nitro and 4-nitro 
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iodobenzenes (Entries 3 and 4). Pleasingly both reactions gave their 
respective products 14 and 15 in high yields, exceeding those previously 
achieved using SPhos by about 30%. 
The reaction conditions were further applied to the coupling of 4 with 
iodobenzene and the relatively electron rich iodoanisoles (Entries 4-7). In all 
cases the yields were comparable if not slightly improved to those 
previously seen using SPhos. 
The success of the high catalyst loading conditions for the cross-coupling 
between 4 and the aryl iodides discussed prompted investigation into use of 
the lower loadings of Pd2dba3 (0.25 mol%) and XPhos (0.5 mol%) (Table 2.2).  
 
Table 2.2: Low loading cross-coupling using XPhos. 
Entry ArI Product SPhosa XPhosb 
1c 
 
13 49 59 
2c 
 
14 34 67 
21 
 
Entry ArI Product SPhosa XPhosb 
3c 
 
15 38 74 
4 
 
16 80 81 
5 
 
17 8 48 
6 
 
18 67 70 
7 
 
19 65 68 
aYields obtained previously in the group.18 b Reaction carried out using 0.25 mol% Pd2dba3 
and 0.5 mol% XPhos. c Organozinc reagent removed from excess zinc.  
The cross-coupling reaction between organozinc reagent 4 and nitro 
iodobenzenes using low loadings of catalyst were used initially (Table 2.2, 
Entries 1-3). The yields for the reactions using XPhos were higher than those 
previously found using SPhos, particulary for the meta- and para- substituted 
nitrobenzene products 13, 14 and 15. 
The low catalyst loading conditions were also applied to iodobenzene and 
the iodoanisoles. As before the desired products were generally obtained in 
comparable yields to those found using SPhos. However the reaction 
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between the ortho-substituted iodoanisole saw a notable increase in yield of 
17 from 8% with SPhos to 40% with XPhos. These results suggest that XPhos 
forms a more active catalyst with Pd2dba3 than SPhos working well at both 
high and low catalyst loading. 
The success of XPhos in the coupling of 4 with the aryl halides discussed 
previously led to the investigation of the Negishi cross-coupling of 4 with 
more challenging electron rich heterocycles. In particular, work in the 
Jackson group has recently looked at the cross-coupling reaction of 
halothiophenes with organozinc reagent 4 (Scheme 2.11).30  
 
 
Scheme 2.11: Negishi cross-coupling of organozinc reagent 4 with 
halothiophenes. 
 
Efforts to couple 2-iodothiophene with organozinc reagent 4 using the high 
loading SPhos (5 mol%)/Pd2dba3 (2.5 mol%) conditions developed in the 
Jackson group were unsuccessful, and only protonation of the organozinc 
reagent was observed (Table 2.3, Entry 1)30. However heating the reaction to 
70 oC yielded 6% of desired product 20 (Entry 2). It has been shown by 
Buchwald and co-workers that biaryl phosphine ligands with a larger steric 
bulk form palladium complexes that are stable at higher temperatures. The 
reaction was repeated using RuPhos at 70 oC and 22% of product 20 was 
isolated (Entry 3). The low yields of these reactions could be attributed to the 
electron rich nature of thiophene. 
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Table 2.3: High catalyst loading Negishi cross-coupling reaction of 2-
halothiophenes with organzinc reagent 4. 
Entry X Temperature 
(oC) 
Ligand Additive Yield (%) 
1 I rt SPhos - 0a 
2 I 70 SPhos - 6a 
3 I 70 RuPhos - 22a 
4 I 50 RuPhos TBAB 50a 
5 I rt XPhos - 31 
6 I 50 XPhos - 49 
7 I 50 XPhos TBAB 29 
8 Br 50 RuPhos - 4 
9 Br 50 XPhos - 44 
Reaction carried out using 2.5 mol% Pd2dba3 and 5 mol% XPhos with the organozinc reagent 
removed from excess zinc. aYields obtained by another member of the Jackson Group.30 
Reactions at higher temperatures than 70 oC were not successful due to the 
degradation of the organozinc reagent. This is thought to occur by an 
intramolecular elimination of the carbamate group (Scheme 2.12).  
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Scheme 2.12: Intramolecular elimination of the organzinc reagent. 
The use of additives was also investigated in the Jackson group as they are 
thought to promote the transmetallation step of a cross-coupling reaction.31 
Knochel and co-workers have previously reported that using LiCl additives 
not only helps zinc insertion into the carbon-halogen bond but also promotes 
transmetallation of the resulting organozinc species.32,33 The use of a range of 
halide additives was explored in the Jackson group and it was found on 
addition of 1.8 eq. of TBAB the isolated yield increased to 50% (Table 2.3, 
Entry 4).30 
The exact mechanism of how halide additives promote the transmetallation 
is still unclear. Organ and co-workers have suggested that the halide 
additive binds to the organozinc reagent to form a higher order zincate 
species which is more active towards transmetallation (Scheme 2.13).31  
 
Scheme 2.13: Reaction of LiBr with the organozinc reagent. 
The use of XPhos in this reaction was investigated to see if the formation of 
the cross-coupled product could be further promoted. The reaction was first 
carried out at room temperature giving an increased yield of 31% (Table 2.3, 
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Entry 5). Previously heating had lead to an increase in yield, so the reaction 
was carried out at 50 oC using XPhos. Pleasingly this again gave an increased 
yield of 49% (Entry 6). 
The main by-product of these Negishi cross-coupling reactions is alanine 
which arises from the protonation of the organozinc reagent. Interestingly in 
the higher yielding reactions involving the coupling of the halothiophenes, 
dehydroalanine was also formed. This could be a result of β-hydride 
elimination after transmetallation of the organozinc reagent with the 
palladium complex (Scheme 2.14). 
 
Scheme 2.14: Mechanism for -Hydride elimination  
With both the use of XPhos and the additive TBAB independently leading to 
an increased yield of the desired cross-coupled product 20, the next step was 
to try combining the two. Thus, a reaction using XPhos and TBAB was 
carried out giving product 20 in 29% yield (Table 2.3, Entry 7). Although the 
yield was still better than the yields achieved using either SPhos or RuPhos 
without additives, it shows that the reaction using XPhos works better 
without the presence of TBAB and vice versa. 
Cross-coupling of organozinc reagent 4 and 2-bromothiophene was also 
investigated. Again it was found that using RuPhos at 50 oC yielded very 
small amounts of the desired product (Table 2.3, Entry 8). However, on using 
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XPhos instead at 50 oC product 20 was obtained in 44% yield, comparable 
with the yield achieved with 2-iodothiophene (Entry 9). 
Cross-coupling of 3-halothiophenes was next examined. Previously 3-
bromothiophene had been found to couple with organozinc reagent 4 in 51% 
yield using RuPhos at 50 oC (Table 2.4, Entry 1). On applying the same 
conditions but using XPhos a small improvement in the yield was seen with 
the product being formed in 60% (Entry 2). The cross-coupling of 3-
iodothiophene was also investigated, firstly using RuPhos, giving product 21 
in 48% yield.  The reaction was then carried out using XPhos both at room 
temperature and 50 oC, both of which saw a small increase in the yield of 21.  
 
 
Table 2.4: High catalyst loading Negish cross-coupling reaction of 3-
halothiophenes with organozinc reagent 4. 
Entry X Temperature 
(oC) 
Ligand Yield (%) 
 
1 Br 50 RuPhos 51a 
2 Br 50 XPhos 60 
3 I 50 RuPhos 48 
4 I 50 XPhos 65 
5 I rt XPhos 55 
Reaction carried out using 2.5 mol% Pd2dba3 and 5 mol% XPhos with the organozinc reagent 
removed from excess zinc. aYields obtained by another member of the Jackson Group.30 
27 
 
Interestingly, these results show that the bromothiophenes couple in 
comparable yields to those of the corresponding iodothiophenes, even 
though the oxidative addition of palladium (0) with the latter is easier. 
However the results also show that the 2- position of thiophene is less 
reactive towards Negishi cross-coupling conditions than the 3- position. 
Having successfully coupled the halothiophenes with organozinc reagent 4 
at higher catalyst loadings (Pd2dba3 (2.5 mol%), XPhos (5 mol%)) the effect of 
reducing the catalyst loading (Pd2dba3 (0.25 mol%), XPhos (0.5 mol%))  was 
investigated (Table 2.5). In the case of both the 3-bromo and 3-iodo 
thiophenes, the product was obtained in moderate yields of 50% and 55% 
respectively. For the 2-bromo and 2-iodo thiophenes, the corresponding 
products were formed in significantly lower yields compared to the 3-
substituted thiophene as previously observed. In all cases a drop of around 
15% from the yields obtained at higher catalyst loading was observed. These 
results suggest that the lower catalyst loading conditions are less suitable for 
reactions with 2-halothiophenes. 
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Table 2.5: Low catalyst loading Negishi cross-coupling reactions of 
halothiophenes with organozinc reagent 4. 
Entry 
 
Yield (%) 
 
1 3-Br 50 
4 3-I 55 
2 2-Br 26 
3 2-I 30 
Reaction carried out using 0.25 mol% Pd2dba3 and 0.5 mol% XPhos with the organozinc 
reagent removed from excess zinc.  
Following the investigations of coupling halothiophenes with organozinc 
reagent 4, the effect of using the XPhos phosphine ligand in the cross-
coupling of 4 with a range of other heteroaromatic halides was explored 
(Table 2.6). 
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Table 2.6: High catalyst loading Negish cross-coupling reaction of 
heteroaromatics with organozinc reagent 4. 
Entry ArX Product Ligand Yield (%)  
1 
 
22 RuPhos 32a 
2 
 
22 XPhos 29 
3 
 
23 RuPhos 19a 
4 
 
23 XPhos 11 
5 
 
26 RuPhos 0 
6 
 
26 XPhos 0 
8 
 
27 RuPhos 0 
7 
 
27 XPhos ~4 
Reaction carried out using 2.5 mol% Pd2dba3 and 5 mol% XPhos. aYields obtained by another 
member of the Jackson Group.18,30 
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Previously, electron rich 3-bromofuran has been successfully cross-coupled 
with iodoalanine derived organozinc reagent 4 in 32% yield catalysed by 
Pd2dba3 and RuPhos.30 The reaction was repeated using XPhos to see if the 
yield of 22 could be further increased, however a similar yield of 29% was 
obtained. 
Using the RuPhos/ Pd2dba3 conditions developed within the Jackson group it 
has been shown that the electron poor heterocycle, 2-bromopyridine, reacted 
to give 23 an excellent yield of 73%. However the same reaction using 2-
chloropyridine not surprisingly gave the product in a much reduced yield of 
19%. Attempting the reaction of 2-chloropyridine and 4 using XPhos saw a 
further reduction in yield to 11% (Table 2.6, Entry 4). These results 
demonstrate that oxidative addition is still a challenge with the stronger 
carbon-chlorine  bonds and that in this case the XPhos/Pd2dba3 catalyst is not 
more active than the RuPhos/Pd2dba3 system. This could possibly be because 
oxidative addition is favoured by an electron rich palladium centre, which is 
provided more by the presence of RuPhos ligands than XPhos.  
The Negishi cross-coupling reactions of electron rich heteroaromatics with 
organozinc reagent 4 was further investigated, looking at the pyrazole 
derived 4-iodopyrazole 24 and N-Boc 4-iodopyrazole 25 (Scheme 2.15). 
 
Scheme 2.15: Synthesis of 4-iodopyrazoles 
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Firstly, reactions of 4-iodopyrazole 24 with organozinc reagent 4 in the 
presence of XPhos and RuPhos were attempted, but only protonated by-
product alanine was isolated (Table 2.6, Entries 5 and 6). To check that the 
protonation was not being caused by the free N-H proton of the pyrazole, N-
Boc 4-iodopyrazole 25 was subjected to the cross-coupling conditions using 
RuPhos and XPhos. In the case of RuPhos, again only the protonated by-
product was isolated. The reaction of XPhos also led to mainly protonated 
material, however there was evidence for a very small amount of the 
coupled product 27 in the 1H NMR spectra although this could not be 
isolated by column chromatography cleanly. These results are not entirely 
surprising as pyrazoles are much more electron rich than any of the other 
heteroaromatics discussed in this chapter. There are no examples of Negishi 
cross-coupling reactions in the literature involving iodopyrazoles as the 
electrophile but there are examples of use in the opposite role as the 
organzinc reagent precursor.34  
2.3.3 Negishi Cross-Couplings using QPhos 
QPhos has been shown to be a suitable ligand in the Pd2dba3 catalysed cross-
coupling reaction of organozinc reagent 4 with 3-haloindoles (Scheme 2.6, 
page 13).26 The Pd2dba3/QPhos catalysed cross-coupling reaction of 
organozinc reagent 4 with some of the previously examined heteroaromatic 
halides was investigated (Scheme 2.16). 
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Scheme 2.16: Negishi cross-coupling of organozinc reagent 4 with 
heteroaromatic halides. 
Yokoyama and co-workers found that for the Pd2dba3/QPhos catalysed cross-
coupling of 3-haloindoles with organozinc reagent 5, 3-bromoindoles 
produced higher yields of the coupled products than 3-iodoindoles. Thus 
reactions using heteroaromatic bromides, 2-bromothiophene and 3-
bromofuran were investigated (Table 2.7, Entries 1 and 2). The cross-
coupling reaction of 4 with 2-bromothiophene gave the product 20 in 25% 
yield. Although this is an improvement on the product yield obtained using 
RuPhos, this is notably less than the 45% gained using XPhos. The reaction of 
3-bromofuran using QPhos gave 22% of the coupled product 22, lower than 
the yields obtained using RuPhos and XPhos.  
In addition to the coupling of heteroaromatic bromides, the reaction of 2-
chloropyridine was also examined to see if the electron rich nature of QPhos 
could help overcome the difficulties of the oxidative addition of palladium(0) 
into the carbon-chlorine bond. The desired product 23 was obtained in 13% 
yield (Table 2.7, Entry 3), suggesting that the Pd2dba3/QPhos catalyst is not 
active enough to overcome the challenges of oxidative addition with carbon-
chlorine bonds. 
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Table 2.7: High catalyst loading Negishi cross-coupling reactions using 
QPhos. 
Entry ArX Product RuPhos 
Yield (%)  
XPhos       
Yield (%)  
QPhos     
Yield 
(%)a 
1 
 
20 4 49 25 
2 
 
22 32b 29 22 
3 
 
23 19b 11 13 
aReaction carried out using 2.5 mol% Pd2dba3 and 5 mol% QPhos. bYields obtained by 
another member of the Jackson Group.18,30 
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2.4 Conclusion 
It has been established that using a combination of Pd2dba3 and XPhos in a 
ratio of 1:2 is an efficient precatalyst for the Negishi cross-coupling reaction 
between the organozinc reagent 4 derived from iodoalanine and aromatic 
halides. This has been demonstrated at both high (5 mol%) and low (0.5 
mol%) catalyst loadings. In several instances the use of XPhos with Pd2dba3 
has been shown to give improved results to those previously obtained using 
SPhos with Pd2dba3. This improvement has been particularly evident in the 
low catalyst loading reactions of ortho-substitued iodoanisole and the 
nitrobenzene iodides with organozinc reagent 4. 
The use of Pd2dba3 and XPhos in the challenging cross-coupling reactions of 
organozinc reagent 4 and electron-rich heteroaromatic halides has also had 
some success. Specifically reactions between 2-iodothiophene and 3-
bromothiophene with 4 have been achieved in modest to good yields 
compared to those previously obtained using alternative phosphine ligands. 
Interestingly yields were not largely affected by altering the halide from 
iodide to bromide, but were affected on changing the position of the halide 
on the thiophene ring. Expanding the use of Pd2dba3 and XPhos in the cross-
coupling reaction of the even more electron-rich imidazole and 4 was 
unsurprisingly not successful. This displays the limitations still present in 
the Negishi cross-coupling of electron rich aromatics. 
Initial investigations using Pd2dba3 and QPhos in the cross-coupling reaction 
of heteroaromatic bromides and 2-chloropyridine with organozinc reagent 4 
have been carried out. In general QPhos was found to be an inferior 
phosphine ligand to XPhos. This factor combined with its relative cost 
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compared to XPhos makes QPhos unsuitable for use in the Negishi cross-
coupling reactions investigated here. 
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3. C-H Activation of Side Chain Amino Acids 
3.1 Introduction  
3.1.1 C-H Activation 
Until recently, the reactions of alkanes have been principally limited to that 
of radical and other oxidation processes, often relying on harsh conditions 
and generating multiple products.35 The hampering of the synthetic 
development of alkane reactions can be attributed to two fundamental 
issues: the inert nature of the C-H bond and the difficulty in selectively 
functionalising a specific C-H bond in a compound containing multiple C-H 
bonds.36 
Over the past decade, C-H activation has become an area of significant 
interest within the field of organic chemistry. The ability to functionalise 
unactivated C-H bonds offers the possibility of new disconnection strategies 
rivalling traditional approaches. Such advances could subsequently provide 
a facile and economical route for the conversion of hydrocarbon feedstocks 
into synthetically useful and industrially important compounds.36 
One of the most widely investigated methods for C-H activation is the 
selective functionalisation of C-H bonds using organometallic systems. Such 
reactions occur by metal induced cleavage (‘activation’) of the C-H bond 
leading to the formation of a C-M bond. This provides a far more reactive 
intermediate, facilitating functionalisation at the carbon centre under much 
milder conditions (Scheme 3.1).37   
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Scheme 3.1: Metal induced activation of C-H bonds. 
Catalytic C-H activation methods have been successfully applied to both sp3 
and sp2 C-H bonds.38 However, due to the low reactivity of the sp3 C-H bond 
compared to that of the sp2 C-H bond, activation of the latter is easier and 
has thus been more extensively investigated. In particular, the activation of 
arenes and heteroarenes has been the subject of several reviews.35,39-41  
Various transition metal catalysts such as those containing Ru,42 Rh,43 Re,44 
Ir,45 Cu46 and Pd47 have been used to promote C-H activation. However, 
palladium complexes have proven to be one of the most versatile catalysts 
for such transformations. In addition to promoting C-H activation with both 
sp3 and sp2 centres,48 palladium catalysts have also shown to assist the 
formation of many new bonds such as carbon-carbon,49 carbon-halogen50 and 
carbon-oxygen.51 Palladium complexes have been shown to work with a 
wide variety of directing groups and are also air and moisture stable.52  
The following review aims to focus principally on the palladium catalysed 
activation of otherwise unreactive sp3 C-H bonds. For a broader coverage of 
this field, there are several reviews that can be examined.35,36,39-41,53-56 
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3.1.2 Directing Groups 
In the majority of sp3 C-H activation reactions, easily cleavable directing 
groups containing heteroatoms are incorporated into the starting material. 
The addition of such groups allows reactions to proceed under milder 
conditions. The reaction proceeds via coordination of a heteroatom to a 
palladium catalyst, facilitating insertion of the palladium into a specific C-H 
bond. The subsequently formed palladacycle 28 can then be functionalised at 
carbon to give 29 (Scheme 3.2).57,58  
 
Scheme 3.2: C-H activation using a directing group. 
Several functional groups have been shown to be effective at directing C-H 
activation, including pyridines, imines, oxime ethers, nitrogen heterocycles 
and amides containing relatively basic oxygen atoms.59,60 
 
3.1.3 Mechanistic Pathways of Sp3 C-H Activation. 
There are several proposed mechanistic pathways for directing group 
induced C-H activations, all of which are thought to proceed through 
cyclopalladated intermediates related to 30 (Scheme 3.3).61  Although passing 
through a similar intermediate, the mechanistic pathways can be divided 
into 2 groups based on the way in which functionalisation of the substrate 
proceeds.  The first is where functionalisation occurs reductively via 
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processes such as reductive elimination and -hydride elimination. In this 
case the cycle is Pd(II)/Pd(0) and the Pd(II) must be regenerated. 
 
Scheme 3.3: Proposed Pd(II)/Pd(0) catalytic cycle for C-H activation 
The second class of C-H activation mechanistic pathway achieves 
functionalisation via electrophilic addition to the palladacycle. The first 
example of this goes via direct cleavage of the Pd-C bond leading to the 
oxidation state of the metal centre remaining unchanged (Scheme 3.4). 
 
Scheme 3.4: Proposed Pd(II)/Pd(II) catalytic cycle for C-H activation 
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The second example involves electrophilic addition of the functional group 
to the palladacycle via an oxidative process to generate a Pd(IV) intermediate 
(Scheme 3.5). Release of the newly functionalised product returns the 
palladium to its catalytically active oxidation state.  
  
Scheme 3.5: Proposed Pd(II)/Pd(IV) catalytic cycle for C-H activation 
3.1.4 Carbon-Oxygen Bond Formation 
An early example of  chelate-directed C-H activation at an sp3 centre was 
reported by Shaw and co-workers in 1978.62 Studies showed that simple 
ketone derivatives, such as oximes and N,N-dimethylhydrazones when 
treated with stoichiometric amounts of Li2PdCl4 and sodium acetate formed 
isolable palladacycle dimers (Scheme 3.6). In this system the oxime acts as a 
directing group with the nitrogen coordinating to the palladium, forming 
palladacycle dimer 31 thus facilitating the C-H activation. 
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The reaction conditions were further developed by Baldwin and co-workers 
in 1985 to allow for functionalisation of the palladacycle.63 It was established 
that addition of pyridine to a cyclopalladated species such as 31 formed a 
further complex, which could then be oxidised with lead(IV) acetate in acetic 
acid, followed by reduction with sodium borohydride, to form a new C-O 
bond leading to acetoxy oxime 32. 
 
Scheme 3.6: Acetoxylation of oximes by Baldwin and co-workers. 
Despite the significance of this C-H activation/functionalisation method, the 
requirement for stoichiometric amounts of palladium made it economically 
impractical. It was therefore necessary to find a method that allowed the 
palladium to be recycled in situ making the reaction catalytic. During the 
reaction Pd(II) is converted into Pd(0) which is unreactive in these systems, 
so an obvious solution was to introduce a stoichiometric oxidant that could 
convert the Pd(0) by-product back to the useful Pd(II) reactant.  
One of the first examples of Pd-catalysed ligand-directed C-H bond 
oxygenation was achieved by Sanford and co-workers in 2004 on sp2 
centres.64  This process involved the use of PhI(OAc)2 as a stoichiometric 
oxidant in combination with catalytic Pd(OAc)2. These conditions were 
subsequently applied to the unactivated sp3 C-H bonds of oxime and 
pyridine derivatives.59 Initial studies looked into the β-functionalisation of 
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pinacolone O-methyl oxime 33 used 5 mol% of Pd(OAc)2 and 1.1 equivalents 
of PhI(OAc)2 (Scheme 3.7). Formation of the palladacycle dimer 34 followed 
by oxidation afforded a mixture of the mono-, bis- and tris-acetoxylated 
products 35, 36 and 37. Increasing the oxidant loading to 4.5 equivalents 
gave the tris-acetoxylated oxime as the major product in a 59% yield. 
Significantly no reaction took place at the more acidic α-C-H bonds which 
would typically display increased reactivity towards electrophilic C-H 
activation.  
 
Scheme 3.7: Acetoxylation of O-methyl oxime 33 by Sanford and co-
workers. 
Functionalisation of a range of O-methyl substituted oximes was examined, 
using the same catalytic conditions, in order to explore the regioselectivity of 
the reaction (Table 3.1).  Entry 2 showed a preference for reaction at the 
primary position over the secondary. This can be explained by a strong steric 
preference for a reaction at the least hindered position. In addition, the 
results showed (Entries 2-3) that the activation occurs at the - over the- 
and -positionThe rationalisation for this lies in the preference for the 
formation of a 5-membered palladacycle rather than a 6- or 7-membered 
analogue. Entries 4-5 show that in the absence of a primary -C-H bond, no 
reaction takes place. The branched substrates were found to give higher 
yields than the linear ones (Entries 2-3). This is most likely due to the 
requirement for co-planarity between the reacting C-H bond and the oxime 
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which is more easily achieved in branched substrates which favour the 
bulkier substituent pointing away from the oxime. 
Table 3.1: Selectivity of Pd(II)/PhI(OAc)2 catalysed sp3 C-H bond oxidation. 
Entry Substrate Major Product Yield (%) 
1 
  
74 
2 
  
78 
3 
  
39 
4 
 
No reaction 0 
5 
 
No reaction 0 
 
The substrate scope was further extended to a wider range of oximes (Table 
3.2).  The substrate in entry 1 had previously been shown to be unreactive 
toward stoichiometric cyclopalladation reactions, however under catalytic 
conditions the acetoxylated product was obtained in good yield. Pyridine 
directing groups (Entries 2-3) were also successfully exploited and have been 
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shown to furnish the mono-, bis- and tris- acetoxylated product in good 
yield. Interestingly the introduction of a linking heteroatom in entry 3 
provided a route for activation at a secondary sp3 C-H centre.  
Table 3.2: Substrate scope of Pd(II)/PhI(OAc)2 catalysed sp3 C-H bond 
oxygenation. 
Entry Substrate Product Yield (%) 
1 
  
61 
2 
  
63 
3 
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The aforementioned work done by Sanford and co-workers provides a 
catalytic, ligand-directed C-H activation method that proceeds with good 
yields and with high levels of regioselectivity. Nevertheless, PhI(OAc)2 is an 
expensive oxidant and produce a stoichiometric amount of PhI. Thus 
investigations were undertaken to establish a greener mode of oxidation that 
would in turn be more practical for large scale synthesis.60 
Previous work had suggested that the C-H activation and oxygenation of 
oximes occurred via a Pd(IV) acetoxy intermediate where the acetoxy ligand 
was obtained from the PhI(OAc)2 oxidant.65 Thus it was postulated that if an 
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external source was used to provide the acetoxy ligand, then an alternative 
oxidant such as a peroxide could be used. A variety of oxidants were 
examined in the presence of acetic acid in the reaction with the sp2 centre of 
oxime ether 38. They were all found to provide the oxygenated product 39, 
with Oxone® and K2S2O8 giving the best results (Scheme 3.8).  
 
Scheme 3.8: Varying the oxidant in the acetoxylation of O-methyl oxime 38 
by Sanford and co-workers 
Oxone® was selected for further trials on a range of substrates due to its low 
cost and safe nature. Of particular interest, it was shown to act as a terminal 
oxidant for sp3 C-H bonds in the same manner as the previously utilised 
PhI(OAc)2 (Table 3.3). In addition to this it was found to have good 
functional group tolerance. 
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Table 3.3: Pd(II)/ Oxone® catalysed acetoxylation of sp3 C-H 
bonds.
 
Building on the work developed by Sanford, Corey and co-workers sought 
to make the methodology applicable to the functionalisation of -amino 
acids such as leucine, alanine, -methyl alanine and phenylalanine.66 Until 
this point, acetoxy functionalistion at the -position of amino acids had not 
been achieved. The suitability of a range of N-phthaloyl--amino acid amide 
derivatives was investigated. Derivatives containing an 8-aminoquinoline 
directing group (which had previously been employed by Daugulis and co-
workers and will be discussed at a later point)67 were determined to be the 
most promising.   
Initial studies looked at the palladium catalysed acetoxylation using either   
t-BuOOH with Ac2O or PhI(OAc)2 with Ac2O. These conditions had 
previously been shown to work with a series of substrates; however the 
reaction afforded none of the desired oxidised product. On addition of 
Mn(OAc)2 to the reaction with t-BuOOH,  conversion to the product 40 was 
observed (Scheme 3.9). 
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Scheme 3.9: Acetoxylation of -amino acid derivatives by Corey and co-
workers.  
It was found that replacement of Mn(OAc)2 with AgOAc, Cu(OAc)2 or 
Co(OAc)2 gave none of the desired product. However, the use of Oxone® 
instead of t-BuOOH with Mn(OAc)2  was shown to give an improved yield 
(Scheme 3.10) proving Oxone®  to be the superior oxidant in this case. 
 
Scheme 3.10: Acetoxylation of -amino acid derivatives by Corey and co-
workers.  
A suggested role for the Mn(OAc)2 additive is as a precursor to the oxidised 
derivative Mn3O(OAc)2 which possesses Lewis acid characteristics. 
Coordination of Mn3O(OAc)2 to the acetoxy ligand increases the positive 
charge on the Pd of the first intermediate 41 lowering the barrier for 
insertion into the C-H bond and facilitating the formation of palladacycle 42 
(Scheme 3.11). Oxone® was found to be an efficient oxidant as it promoted 
rapid oxidation of Pd(II) species 42, allowing for -acetoxylation. At a slower 
rate of oxidation, decomposition routes such as -H elimination or Pd-C 
homolysis could take precedence. Nitromethane was used as solvent due to 
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its non-coordinating, polar nature which maximises the electrophilicity of 
the palladium species. 
 
Scheme 3.11: Proposed mechanism for the acetoxylation of -amino acid 
derivatives by Corey and co-workers.  
Yu and co-workers have also reported the palladium catalysed oxidation of 
unactivated methyl groups utilising oxazoline directing groups (Scheme 
3.12).68 Initial work showed that use of the peroxyester MeCOOOtBu as the 
stoichiometric oxidant and Ac2O as a promoter was efficient in the 
regeneration of the Pd(II) catalyst. Acetoxylation of 43 was shown to occur in 
good yield.     
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Scheme 3.12: Acetoxylation of methyl groups by Yu and co-workers.  
A wide range of substrates were oxidised, with the reaction conditions found 
to tolerate imides, esters and chlorides. The conditions were then altered in 
order to induce diastereoselective acetoxylation, by using a chiral oxazoline, 
but it was found that the oxidant MeCOOOtBu was not compatible. This was 
due to the -H now present in the oxazoline which could allow oxidation to 
the oxazole. Thus the oxidants lauroyl and benzoyl peroxide were employed 
on a range of substrates containing prochiral methyl groups. Moderate to 
good diastereoselective enrichments of 56:44-91:9% were observed (Scheme 
3.13).  
 
Scheme 3.13: Diastereoselective acetoxylation of methyl groups by Yu and 
co-workers. 
3.1.5 Carbon-Halogen Bond Formation 
Carbon-halogen bond formation provides a synthetically useful stepping 
stone to various other functionalities. One of the first examples of C-H 
activation followed by halogenation was reported by Sutherland and co-
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workers.69 Previously developed conditions using stoichiometric amounts of 
Na2PdCl4 in addition to NaOAc, and AcOH were employed for the 
formation of the lanost-8-en-3-one cyclopalladated dimer 44.62 The dimer 
was then reacted with triphenylphosphine to furnish the monomer 45 as a 
crystalline solid. Further reaction of the monomer 45 with iodine yielded the 
iodinated product 46 (Scheme 3.14). 
 
Scheme 3.14: Iodination of Lanost-8-En-3-One by Sutherland and co-
workers. 
More recently Yu and co-workers have reported the chemoselective and 
asymmetric, catalytic iodination of methyl groups located at the -position 
of saturated aliphatic acids.70 The C-H activation in these systems was again 
mediated by - chelating auxiliaries such as oxazolines (Scheme 3.15). Both 
AgOAc and PhI(OAc)2 were shown to be capable of converting the 
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unreactive PdI2 by-product back to Pd(OAc)2, with the latter furnishing 
slightly better yields. 
 
Scheme 3.15: Iodination of methyl groups by Yu and co-workers. 
A range of substrates derived from the corresponding carboxylic acids and 
(S)-tert-leucinol was examined (Table 3.4). The selective activation of 
primary over secondary C-H bonds was conclusively demonstrated by entry 
2 in which only the -C-H of the R=Me was activated. Interestingly, this 
entry was also found to display a moderate degree of diastereoselectivity 
(63:37). This encouraged investigation into the asymmetric iodination of 
various prochiral substrates. Entries 3 and 4 were accessed with significant 
diastereoselectivity. 
Table 3.4: Pd(II)/PhI(OAc)2 catalysed monoiodination of methyl groups.  
 
Entry R Yield (%) dr 
1 Me 92 N/A 
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Entry R Yield (%) dr 
2 Et 88 63:37 
3 tBu  83 91:9 
4 OTBDMS  62 93:7 
 
The increase in diastereoselectivity from entries 2 to 3 can be explained by 
looking at the steric repulsion (Figure 3.1).71 When R1 is larger than the Me 
group, 47 is favoured over 48. This minimises any steric interaction between 
the R2 group at the stereogenic centre of the oxazoline directing group and 
therefore the selectivity of the C-H activation can be controlled, particularly 
when both R1 and R are sterically bulky.  
 
Figure 3.1: Model for the diastereoselective iodination of amino acid 
derivatives by Yu and co-workers. 
Continuing from this the substrate range was extended. The 
diastereoselective iodination conditions were found to tolerate a number of 
functional groups including halides, esters, ethers and imides. In particular 
use of the phthalimide protecting group was investigated, which had been 
successfully applied in related work carried out by Corey and co-workers 
(Scheme 3.16). Only a small amount of diastereoselectivity was observed 
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suggesting the phthalamide group is not bulky enough to induce high levels 
of selectivity. 
 
Scheme 3.16: Diastereoselective iodination of amino acide derivatives by 
Yu and co-workers. 
Yu and co-workers discovered that by variation of the oxazoline and 
oxidant/iodine loadings, multiple C-H activations could occur, thus yielding 
not only the mono- but the bis- and tris- iodinated products as well (Table 
3.5).72  
Table 3.5: Pd(II)/PhI(OAc)2 catalysed mono, bis- and tris- iodinationion of 
2-(tert-Butyl)dimethyloxazoline. 
 
Formation of the bis-iodinated product provides an intermediate in the 
transformation of gem-methyl groups into cyclopropanes (Scheme 3.17). 
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Scheme 3.17: Synthesis of cyclopropanes by Yu and co-workers. 
More recently, related studies have been undertaken within the Jackson 
group. The initial aims of this project were to perform a C-H activation on 
the -methyl group of L-alanine 49, followed by the formation of a carbon 
iodine bond (Scheme 3.18).73 
 
Scheme 3.18: Iodination of alanine  
As already described, Corey and co-workers have successfully developed a 
method for the C-H activation and subsequent acetoxylation of -amino 
acids (Page 47, Scheme 3.10).66 In particular the phthalimide protected L-
alanine, in combination with an 8-aminoquinoline directing group was 
found to be a suitable substrate for such reactions. Thus it was deduced that 
50 might also be exploited in a C-H activation/iodination process using the 
conditions developed by Yu and co-workers.70,71 
Initial results found that using Yu’s conditions, substrate 50 formed two 
products: the mono iodinated product at the aromatic position 51 and the 
bis-iodinated product 52 (Scheme 3.19). It had been noted in the literature 
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that a combination of iodine and PhI(OAc)2 could iodinate aromatic 
substrates, due to the formation of acetyl hypoiodite.74 This was tested by 
reacting substrate 50 in the presence of PhI(OAc)2  and iodine and not 
surprisingly aromatic iodide product 51 was formed in 80% yield. However, 
the presence of bis-iodinated product 52 from the reaction with palladium 
showed that C-H activation was taking place, thus the 8-aminoquinoline was 
an effective directing group.  
 
Scheme 3.19: Work towards the side chain iodination of alanine by 
Jackson and co-workers. 
The conditions were varied in an effort to try and improve the yield of the 
bis-iodinated product 52. Screening of solvents and temperature found that 
the reaction at 40 oC in CH2Cl2 gave the best conversion to the bis-iodinated 
product (Scheme 3.20). However, it became apparent that the reaction was 
stoichiometric in Pd, suggesting that PhI(OAc)2 was not a suitable reagent for 
converting PdI(OAc) back to Pd(OAc)2.  
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Scheme 3.20: Work towards the side chain iodination of alanine by 
Jackson and co-workers. 
The inability of PhI(OAc)2 to regenerate Pd(OAc)2 was confirmed when the 
reaction was repeated in the absence of PhI(OAc)2 (Scheme 3.21). This time 
the reaction produced the desired mono-iodinated product 53 in 10% yield, a 
stoichiometric amount relative to Pd, proving that PhI(OAc)2 was only 
involved in the aromatic iodination, and not in the regeneration of the Pd(II) 
catalyst. The reaction was repeated using Pd(OAc)2 and 50 in a 1:1 ratio 
giving 53 in 70% confirming that the reaction was stoichiometric in terms of 
Pd(OAc)2. 
 
 
Scheme 3.21: Work towards the side chain iodination of alanine by 
Jackson and co-workers.  
It was apparent that an alternative to the PhI(OAc)2 was needed. Yu and co-
workers had reported the use of AgOAc as a suitable additive in similar 
processes, so the reaction was repeated with the AgOAc in place of 
PhI(OAc)2  (Scheme 3.22).71 These conditions were found to produce the 
desired mono-iodinated product. However to obtain higher yields of 
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product 53 the reaction vessel had to be unsealed and the initial 
concentration of 50 in solvent had to be carefully controlled to subdue the 
formation of by-products 51 and 52. The best yield obtained was 60% after 24 
hours starting at 0.1 M concentration on a 0.14 mmol scale, but the use of an 
open reaction vessel meant the reproducibility of these results proved 
difficult due to variable solvent evaporation. The reactions were carried out 
in deuterated solvent, in order to monitor the conversion of 50 to 53 and the 
presence of any possible intermediates. 
 
Scheme 3.22: Side chain iodination of alanine by Jackson and co-workers. 
The effect of AgOAc on by-product formation can be understood by 
examining the intermediates in the reaction. After one catalytic turnover 
forming the C-I bond the Pd(OAc)2 is converted to intermediate Pd(OAc)I 
(Scheme 3.23).  The AgOAc reacts with the Pd(OAc)I thus regenerating the 
Pd(OAc)2 catalyst, with the formation of AgI. Simultaneously AcOI is formed 
by the reaction of AgOAc with I2, which then iodinates the aromatic system 
of the starting material, forming the unwanted by-product. This process was 
inhibited by controlling the initial concentration of the reaction, it was found 
going above 0.1 M lead to more aromatic iodination. 
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Scheme 3.23: The effect of AgOAc on by-product formation. 
Ag2CO3 was then investigated as an alternative additive. In addition to 
giving an improved yield of the desired product, it gave much less of the bis-
iodinated product and the reaction could be carried out in a closed system 
and was more reproducible (Scheme 3.24). Despite this, the reaction was 
only found to work on 0.14 mmol scale, and efforts to increase the scale were 
unsuccessful. 
 
Scheme 3.24: Side chain iodination of alanine by Jackson and co-workers 
It appears likely that this improvement is due to the lower solubility of 
Ag2CO3 in CDCl3 compared to AgOAc. It can be explained by looking at the 
reaction stoichiometrically in Pd (Scheme 3.25). As the C-H activation occurs, 
only then is AcOH generated. The AcOH can then react with the Ag2CO3 to 
form AgOAc. The AgOAc then goes into solution and reacts with the Pd(II) 
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intermediate to regenerate Pd(OAc)2 thus limiting the formation of the 
undesired hypoiodite species.  
 
Scheme 3.25: The effect of Ag2CO3 on by-product formation. 
3.1.6 Carbon-Carbon Bond Formation 
Selective, catalytic activation of C-H bonds, followed by the formation C-C 
bonds is an important goal for synthetic chemistry and is an area that is 
under developed. Daugulis and co-workers designed a system for the 
palladium catalysed arylation of acetanilide derivatives and pyridines using 
a Pd(OAc)2 catalyst with stoichiometric AgOAc.75 They were then able to 
extend this to unactivated sp3 bonds using a chelating pyridine functionality 
to facilitate the C-H activation step (Scheme 3.26).76 
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Scheme 3.26: Arylation of acetanilide derivatives by Daugulis and co-
workers. 
Initial investigations employed the pyridine-2-yl-methyl moiety to direct 
arylation. However this was found to be susceptible to C-H activation of the 
benzylic methylene group in some cases. As a result 8-aminoquinoline was 
utilised due to its lack of benzylic C-H bonds. -Arylation successfully 
occurred on several carboxylic acid derivatives with high regioselectivity. 
Interestingly, it was found that secondary C-H bonds reacted more quickly 
than primary C-H bonds (Scheme 3.27). 
  
Scheme 3.27: -Arylation of carboxylic acid derivatives by Daugulis and 
co-workers. 
A similar approach was found to be applicable for arylation of amine 
derivatives using 2-picolinic acids (Scheme 3.28). 76  
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Scheme 3.28: Arylation of amine derivatives by Daugulis and co-workers. 
Shortly thereafter, Corey and co-workers reported the synthesis of -arylated 
leucine derivatives (Scheme 3.29).66 Again using 8-aminoquinoline as the 
directing group to coordinate the palladium catalyst forming a palladacycle, 
a series of aryl groups with varying functionalities were successfully 
introduced in good yields with high diasteroselectivity. 
 
 
 
Scheme 3.29: Arylation of Leucine derivatives by Corey and co-workers. 
This strategy has since been implemented as a key step in the total synthesis 
of Celogentin C 54 carried out by Feng and co-workers in 2010 (Figure 3.2).77  
Stereoselective -C-H activation took place on the Leu substrate 55 forming a 
palladacycle intermediate. This then presumably underwent cross-coupling 
with the iodoindole to provide the arylated product (Scheme 3.30). The core 
structure 56 underwent several further reactions to give the desired product 
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54. A similar route using the key C-H activation step was also reported by 
Hutton and co-workers shortly after.78 
 
 
Scheme 3.30: Arylation of Leucine derivative 55 by Feng and co-workers. 
  
 
Figure 3.2: Celogentin C 
Taking the lead from Corey and co-workers,66 more recently Daugulis and 
co-workers have further extended the work to C-H activation followed by 
arylation to produce a range of unnatural amino acids using both low 
temperatures and low loadings of Pd(OAc)2 (Scheme 3.31, Table 3.6).79  
 
63 
 
 
Scheme 3.31: Arylation of amino acid derivatives by Daugulis and co-
workers. 
Table 3.6: C-H activation and arylation to give unnatural amino acids. 
Entry R Ar Yield (%) d.r. 
1 H 
 
81a na 
2 
Ph 
 
91 24:1 
3 Ph 
 
95 50:1 
4 iPr 
 
77 50:1 
5 iPr 
 
80 24:1 
aProduct doubly arylated 
Babu and co-workers have reported the diastereoselective synthesis of 
mono- and diaryl cyclopropanecarboxamides using  similar methodology 
(Scheme 3.32).80 Once again 8-aminoquinoline was used to selectively direct 
Pd(OAc)2 into the C-H bond of the cyclopropane ring forming a palladacycle 
that subsequently can be reacted with a range of aryl iodides. As seen 
previously AgOAc was also found to be the most suitable reagent for 
regeneration of the Pd(OAc)2. 
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Scheme 3.32: Diastereoselective synthesis of mono- and diaryl 
cyclopropanecarboxamides by Babu and co-workers. 
The scope of this cyclopropanecarboxamide arylation reaction was first 
examined where R=H, using a variety of aryl iodides containg both electron 
withdrawing and donating groups (Table 3.7). All substrates generally gave 
moderate to good yields of the corresponding diastereoslectively formed 
disubstitued cyclopropanes with cis stereochemistry. 
 
 
Table 3.7: Cyclopropanecarboxamide arylation reaction. 
Entry Ar Yield (%) 
1 
 
69 
2 
 
28 
3 
 
69 
65 
 
Entry Ar Yield (%) 
4 
 
67 
5 
 
78 
6 
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Chatani and co-workers have shown that the 8-aminoquinoline group can 
also be used to direct the sp3 C-H activation and direct alkynylation using 57 
on a range of aliphatic carboxylic acid derivatives (Scheme 3.33).81  The 
reaction was found to be tolerant of a wide range of functional groups in 
addition to coping well with the presence of sterically demanding groups 
cyclohexyl and isopropyl (Table 3.8, Entries 1 and 2). However, whilst 
working well with secondary C-H bonds, the functionalisation of primary 
and tertiary C-H bonds occurs with much lower efficiency. 
 
Scheme 3.33: Alkynylation on a range of aliphatic carboxylic acid 
derivatives by Chatani and co-workers. 
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Table 3.8: Pd-Catalyzed Direct Alkynylation of Aliphatic C-H Bonds with 
57. 
Entry R Yield (%) 
1 iPr 64 
2 Cy 66 
3 OMe 60 
4 CF3 42 
5 Ph 73 
 
 
Yu and co-workers have developed a method for both sp2 and sp3 pyridine 
directed C-H activation followed by alkylation using either methylboroxine 
or alkyl boronic acids.48  Using boroxine as an alkyl source, a mixture of 
Cu(OAc)2 and benzoquinone oxidants were found to be suitable for the 
regeneration of the Pd(II) (Scheme 3.34).  However, the boroxine was only 
viable for delivering a methyl group. Use of ethyl- or butyl-boroxines as 
coupling partners failed to give any of the desired alkylated products. 
 
 
 
Scheme 3.34: Sp3 alkylation by Yu and co-workers. 
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In an attempt to solve this problem a variety of boronic acids was examined 
applying the previously developed catalyst and oxidation method. However, 
these reactions were unsuccessful. A wider range of additives and solvents 
were investigated to try and promote the alkylation reaction. A mixture of 
Ag2O and benzoquinone was found to provide moderate yields of the C-C 
coupling product (Scheme 3.35). Both these reaction conditions were found 
to be compatible with ether, alcohol and ester groups.  
 
Scheme 3.35: Sp3 alkylation by Yu and co-workers. 
Subsequent work by the group provided examples of -arylation of aliphatic 
acids with organoboron reagents.38 The reaction proceeded via the in situ 
formation of a carboxylate which in turn acts as a directing group mediating 
the C-H activation (Scheme 3.36). Phenylboronate 58 was then reacted with 
the activated intermediate to form the arylated product. A range of 
substrates were found to react giving a modest yield. 
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Scheme 3.36: -arylation of aliphatic acids by Yu and co-workers. 
To demonstrate the generality of the C-H cleavage and C-C bond forming 
reactions, arylation was carried out using iodobenzene (Scheme 3.37). 
Alteration of the previous protocol by omitting the benzoquinone and 
adding NaOAc gave a good combined yield of the mono and diarylated 
products. 
 
Scheme 3.37: -arylation of aliphatic acids by Yu and co-workers. 
More recently Yu and co-workers have reported the -arylation of N-
pentafluoroamides.82 It was suggested that installing an electron 
withdrawing group on the amide would reduce the nucleophilicity of the 
nitrogen atom. In addition to suppressing the possible Buckwald-Hartwig 
amination on addition of an aromatic iodide, this would also allow for easy 
deprotonation of the amide. The deprotonated amide would be free to 
coordinate to the palladium alongside the carbonyl oxygen, forming a 
palladacycle, thus promoting the C-H activation. It was found that using 
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CONH-C6F5 as a directing group with Buchwald’s cyclohexyl JohnPhos 
ligand and CsF as a base allowed for the formation of the arylated product 
when coupled with an aromatic iodide (Scheme 3.38). Both mono- and di-
arylated products were observed depending on which substrate was used. 
 
Scheme 3.38: -Arylation of N-pentafluoroamides by Yu and co-workers. 
The reactivity of other electron-withdrawing directing groups was further 
examined.83 It was found that sp3 C-H olefination of N-arylpivalamide 59 
with benzyl acrylate followed by an intramolecular 1,4 addition of the amide 
to the newly introduced acrylate led to the corresponding -lactam (Scheme 
3.39). A range of N-aryl amides was investigated and it was found that 
electron withdrawing groups on the aromatic ring greatly improved the 
yields.   
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Scheme 3.39:Olefination of N-aryl amides by Yu and co-workers. 
 
The possibility of arylation of acyclic and cyclic -methylene sp3 C-H bonds 
using electron withdrawing groups was further investigated (Scheme 3.40).84  
The amide coordinates to Pd(O2CCF3)2  allowing for the formation of the 
palladacycle which then reacts with the aryl iodide to give the desired 
product. Ag2CO3 and K2HPO4 are then used to regenerate the active Pd(II) 
catalyst. In this case the addition of the ligand 60 was found to accelerate the 
reactions by coordinating to the Pd(II) centre and promoting the otherwise 
sluggish reductive elimination step.  A range of -arylated products in good 
yields was obtained (Table 3.9).  
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Scheme 3.40: -Arylation of N-pentafluoroamides by Yu and co-workers. 
Table 3.9: Arylation of methylene sp3 C−H bonds. 
Entry R1 R2 Ar Yield (%) 
1 Me H 
 
77 
2 
Me H 
 
71 
3 Me H 
 
68 
4 Et H 
 
55 
5 Me iPr 
 
82 a 
aSingle diastereoisomer 
Yu and co-workers have also investigated the alkynylation of sp3 β-C−H 
bonds in aliphatic amides using a Pd(0) catalyst in combination with the N-
heterocyclic carbene IAd·HBF4 (Scheme 3.41).85 In this case the work focused 
on the activation of a primary C-H bond but again showed good functional 
group tolerance and gave the expected products in good yields (Table 3.10). 
One large drawback of this method is that the reaction is carried in Et2O at 85 
oC in a sealed vessel making it relatively dangerous.  
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Scheme 3.41: Alkynation of N-pentafluoroamides by Yu and co-workers. 
Table 3.10: β-Alkynylation of carboxylic acid amides. 
Entry R Yield (%) 
1 nPr 81 
2 H 62 
3 Me 70 
4 Et 78 
5 Cy 70 
6 CF3 77 
7 OBn 79 
 
3.1.7 Enantioselective C-H activation 
In recent years, C–H activation/functionalisation has emerged as a viable 
strategy for the synthesis of natural products as previously described. 
However in order to extend the scope of these transformations, the ability to 
perform C-H activations enantioselectively would be an advantage. 
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However, despite the success in asymmetric palladium catalysis, the 
enantioselective functionalisation of C-H bonds through palladium insertion 
has been for the most part unsuccessful.55 Yu and co-workers have suggested 
two problems that have encumbered development in this area. The first is 
that the relatively high temperatures that are required in many C-H 
activation reactions make chiral recognition of the sp3 carbon centre difficult. 
Secondly, the reaction requires an external chiral ligand to coordinate to the 
Pd(II) species in order to control the chemo-, regio- and stereoselectivity of 
insertion into the C-H bond. However, most commonly used chiral ligands 
can preferentially bind to the Pd(II) centre over the substrate or deactivate 
the Pd(II) towards cleavage of the desired C-H bond.86 
Yu and co-workers have undertaken pioneering work in the development of 
asymmetric activation of prochiral C(sp2)-H and C(sp3)-H bonds followed by 
C-C bond formation to give enantioenriched products (Scheme 3.42).87 
 
 
Scheme 3.42: Asymmetric activation of prochiral C(sp3)-H bonds by Yu and 
co-workers. 
 
The initial goal was to find a suitable catalytic system that would work on 
the prochiral substrate, facilitating C-H activation and subsequent alkylation 
in a non-stereoselective manner. Previously developed conditions by the 
group using Pd(OAc)2 in the presence of the additives benzoquinone and 
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Ag2O followed by addition of the organoboron species, were found to 
convert starting material 61 to product 62 in excellent yield (Scheme 3.43).48 
 
 
Scheme 3.43: Asymmetric activation of prochiral C(sp3)-H bonds by Yu and 
co-workers. 
 
Chiral carboxylates were employed as the ligand in the hope that along with 
the constrained conformation of the nitrogen coordinated palladium 
intermediate, asymmetric induction would occur. Enantiomeric excess’ of up 
to 20% were obtained, leaving room for improvement. The low 
enantioselectivity observed was attributed to the relatively free rotation of 
the chiral moiety of the carboxylic acid ligand. Thus the use of chiral 
cyclopropane amino acid groups as ligands was examined (Figure 3.3). A 
marked improvement in the enantioselectivity of the product was observed. 
Interestingly, whilst the opposite enantioselectivities between 63 and 64 were 
expected, the switch of chiral induction between 64 and 65 suggested that the 
chirality of the -carbon centre plays the dominant role. 
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Figure 3.3: Chiral ligands used activation of prochiral C(sp3)-H bonds by 
Yu and co-workers. 
 
Upon additional investigation, it was found that a wide range of 
monoprotected amino acids were even more effective chiral ligands for this 
enantioselective coupling reaction (Table 3.11). C-H activation/C-C coupling 
of 61 in the presence of Boc-L-leucine gave the alkylation product 62 in 90% 
ee. and 63% yield.  
Systematic structural changes were made to the chiral ligand to probe the 
scope of the reaction. Removal of the Boc group on the ligand (Entry 2) lead 
to a full recovery of the starting material suggesting that an electron 
withdrawing group attached to the nitrogen is required in order to maintain 
the electrophilicity of the Pd(II) catalyst for C-H activation. Esterification of 
the carboxylic acid (Entry 3), resulted in complete loss of enantioselectivity of 
product 62. Reduction of the size of the nitrogen protecting group from a Boc 
to a acetyl (Entry 4) also saw a decrease in the enantioselectivity. Changing 
the nitrogen protecting group to menthyl carbamate (Entry 5) gave again 
high enantioselectivity as well as a markedly improved yield. 
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Table 3.11: Influence of the ligand on enantioselectivity of the butylation 
of 61. 
Entry Ligand Yield (%) ee (%) 
1 
 
63 90 
2 
 
0 0 
3 
 
86 0 
4 
 
74 80 
5 
 
91 87 
  
Using the conditions described above, in addition to a chiral ligand, the C-H 
activation and alkylation reaction was attempted on the sp3 C-H bonds of 66 
(Scheme 3.44). Poor selectivities were observed using the L-leucine derived 
ligands (10-15% ee). However an improved enantioselectivity of 37% was 
observed with the use of the cyclopropane amino acid 63. This result 
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suggests that the chiral ligand could be further tuned for this class of C-H 
activation reaction. 
 
Scheme 3.44: Alkylation of prochiral C(sp3)-H bonds by Yu and co-
workers. 
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3.2 Aims 
Previous work within the Jackson group has developed a method for the 
iodination of a phthaloylalanine derivative in the presence of an 8-
aminoquinoline group using palladium catalysed C-H activation (Scheme 
3.24). Unfortunately all efforts to scale up the reaction above a 0.14 mmol 
scale were unsuccessful. 
 
 
Scheme 3.24: Side chain iodination of alanine derivative 50. 
 
The first aim of this project is to make this reaction scaleable and thus more 
useful as a synthetic tool. Subsequent aims include the side-chain iodination 
of a range of amino acid derivatives (Scheme 3.45). 
  
 
Scheme 3.45: Side chain iodination of amino acid derivatives 
 
The second area of interest is to investigate the reactivity of iodide 53, in 
particular employing Negishi cross-coupling conditions to synthesise phenyl 
alanine derivatives (Scheme 3.46). If successful this would represent a 
potentially general method for the functionalisation of the methyl side chain 
of alanine. 
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Scheme 3.46: Negishi cross-coupling of iodoalanine 53. 
The third area of interest is to apply this approach to the C-H activation of 
lactic acid (Scheme 3.47). Initial investigations will apply the acetoxylation 
chemistry developed by Corey and co-workers and the iodination method 
already developed within the Jackson group.  
 
Scheme 3.47: Side chain iodination of lactic acid derivative. 
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3.3 Results and Discussion 
3.3.1 Carbon-Iodine Bond Formation 
3.3.1.1 Alanine derivative 
Initial work began with the synthesis of N-phthaloylalanine amide derivative 
50. L-Alanine was heated to 160 oC with phthalic anhydride to give phthaloyl 
protected alanine 67. Using the method previously developed in the group 
compound 67 was converted to the corresponding acid chloride using 
thionyl chloride.73 Subsequent removal of excess thionyl chloride and 
addition of 8-aminoquinoline and Hünig’s base furnished the desired 
product in 82% yield and 99% ee. as determined by chiral HPLC  (Scheme 
3.48). It should be noted that previous synthesis of 50 in the Jackson group 
using NEt3 instead of Hünig’s base, as carried out by Corey and co-workers, 
caused racemisation of 50.66,73 
 
Scheme 3.48: Synthesis of alanine derivative 50. 
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With compound 50 in hand, it was decided to repeat the C-H 
activation/iodination reaction recently developed in the group on a 0.14 
mmol scale (Scheme 3.24). Addition of iodine, catalytic Pd(OAc)2 and 
stoichiometric Ag2CO3 gave the desired iodinated product 53 in 68% yield, 
comparable with previous results.73  
 
Scheme 3.24: Side chain iodination of 50 on a 0.14 mmol scale. 
With assurances that the reaction was reproducible on a small scale, it was 
decided to next look and see whether improvements could be made (Table 
3.12). Use of an excess of Ag2CO3 was initially examined, but was found to 
hinder the reaction. Increasing the amount of iodine was examined to see if 
the yield of iodide 53 could be increased. Addition of 2 equivalents of iodine 
compared to the previous 1.3, saw an increase of 4% in yield. Although not a 
substantial increase, it was decided to use this amount for further reactions. 
The next component to be investigated was the loading of the Pd(II) catalyst. 
The previous reactions had employed 10 mol%, hence loadings of 5 and 1 
mol% were examined and found to yield 53 in 66% and 56% respectively. 
From this, it suggested 5 mol% Pd(OAc)2 could successfully be employed for 
this reaction. 
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Table 3.12: Optimisation of 0.14 mmol scale reaction. 
Entry Pd(OAc)2 (eq.) Ag2CO3 I2 (eq.) Yield 53 (%) 
1 0.1 1 1.3 68 
2 0.1 1.3 1.3 59 
3 0.1 1 2 72 
4 0.05 1 2 66 
5 0.01 1 2 54 
Reactions carried out at 0.1 M concentration with respect to compound 50 in CHCl3 at rt for 3 
days. 
Having undertaken this groundwork for the reaction, the issues of scalability 
were considered. Previous attempts at scaling had been unsuccessful 
meaning all reactions had been limited to a 0.14 mmol scale. In order for this 
iodination reaction to be a viable synthetic strategy it would be necessary to 
get the reaction working at least on a 1 mmol scale. To start with the scale 
was doubled to 0.3 mmol with respect to starting material 50 (Table 3.13).  
The lower yield obtained (27%) suggests that 5 mol% Pd(II) loading was not 
feasible at this increased scale (Entry 1). Although use of 10 mol% Pd(II) 
loading did give an improved yield increase, it was still significantly less 
than the yields achieved on the smaller scale. Attempts at both lowering and 
increasing the temperature both saw reductions in yield.  
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Table 3.13: Optimisation of 0.3 mmol scale reaction. 
Entry Pd(OAc)2 
(eq.) 
Temp. 
(oC) 
CHCl3 
(mL) 
Concentration 
of 50 (M) 
Yield 
53 (%) 
Yield 
52 (%) 
1 0.05 rt 3 0.1 23 a- 
2 0.1 rt 3 0.1 51 a- 
3 0.1 40 3 0.1 34 a- 
4 0.1 0 3 0.1 38 a- 
5 0.1 rt 2 0.15 59 a- 
6b 0.1 rt 2 0.15 45 28 
aTrace amount observed in 1H NMR spectrum, bSolvent completely evaporated. Reactions 
carried out on 0.3 mmol scale with respect to compound 50 with 1 eq Ag2CO3 and 2 eq I2 for 
3 days. 
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The effect of increasing the concentration of the reaction was then 
investigated. Two reactions were carried out using 2 mL of solvent to give 
increased 0.15 M concentrations. In one of the cases the yield increased to 
59% suggesting that concentration played a large role in the efficiency of 
these reactions. In the second case, the solvent evaporated completely. This 
interestingly led to almost complete consumption of the starting material. 
However, rather than just producing desired product 53, bis-iodinated 
product 52 was also observed.                          
The scale of reaction was further increased using 0.6 mmol of starting 
material. Again, using 2 eq. I2, 0.1 eq. Pd(OAc)2 and 1 eq. Ag2CO3,  a set of C-
H activation/iodination reactions in which the concentration was varied were 
carried out (Table 3.14). For previous experiments the reaction time had been 
3 days, however on monitoring the reactions via 1H NMR spectroscopy, no 
further reaction of the starting material was seen up to 7 days. 
It was found that by decreasing the volume of solvent from 6 to 3 mL (on a 
0.6 mmol scale), thus increasing the concentration of reactants, the yield of 
the desired C-H activated product could be increased. However, upon 
decreasing the volume further, the yield of the unwanted bis-iodinated side 
product increased. It was therefore found that on a 0.6 mmol scale 
comparable yields to those previously obtained on a 0.14 mmol scale could 
be achieved, although isolation was complicated by the presence of the bis-
iodinated by-product 52. 
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Table 3.14: Optimisation of 0.6 mmol scale reaction. 
Entry CHCl3 
(mL) 
Concentration 
of 50 (M) 
Yield 53 
(%) 
Yield 52 
(%) 
Total C-H 
activation (%) 
1 6 0.1 41 -a 43 
2 5 0.12 48 8 56 
3 4 0.15 53 7 70 
4 3 0.2 67 11 78 
5 2 0.3 48 24 72 
6 1 0.6 43 32 75 
aTrace amount observed in 1H NMR spectrum. Reaction carried out over 3 days. Reactions 
carried out on 0.6 mmol scale with respect to compound 50 with 1 eq Ag2CO3, 0.1 eq 
Pd(OAc)2 and 2 eq I2 for 7 days. 
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The initial aim was to get the C-H activation/iodination working at a 1 mmol 
scale. The optimum conditions for the 0.6 mmol scale were applied at the 1 
mmol scale (Table 3.14, Entry 4). However on use of these conditions, the 
yield decreased significantly (Entry 1). It was again decided to try and 
increase the yield by increasing the reaction concentration. This was not as 
successful as it had been previously. Although the overall C-H activation 
and iodination of the side chain did noticeably increase, the unwanted 
aromatic iodination also increased concurrently.  
Table 3.15: Optimisation of 1 mmol scale reaction. 
Entry CHCl3 
(mL) 
Concentration of 
50 (M) 
Yield 
53 (%) 
Yield 
52 (%) 
Total C-H 
activation (%) 
1 6 0.16 26 4 30 
2 4 0.25 35 14 49 
3 2 0.5 39 22 61 
4 1 1 45 32 77 
Reactions carried out on 1 mmol scale with respect to compound 50 with 1 eq Ag2CO3, 0.1 eq 
Pd(OAc)2 and 2 eq. I2 over 7 days. 
It was next envisaged that by maintaining a low volume of solvent, but 
decreasing the loading of iodine, the extent of bis-iodination could be 
retarded. Reduction in the amount of iodine (from 2 to 1.5 eq.) gave 68% 
yield of desired product 53 in addition to 9% of by-product 52 (Table 3.16). 
Surprisingly, it was found that by decreasing the amount of iodine to 1.2 and 
1.0 equivalents a huge decrease in yields, to 19 and 3% respectively, was 
observed. 
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Table 3.16: Optimisation of 1 mmol scale reaction. 
Entry I2 
(eq.) 
Yield 53 
(%) 
Yield 52 
(%) 
Total C-H 
activation (%) 
1 2 45 32 77 
2 1.5 71 11 87 
3 1.2 19 0 19 
4 1 3 0 3 
Reactions carried out on 1 mmol scale and 1 M concentration with respect to compound 50 
with 1 eq. Ag2CO3 and 0.1 eq Pd(OAc)2 over 7 days. 
With the result obtained in entry 2, the reaction time was investigated. It was 
found that the reaction could be successfully carried out over 5 days rather 
than the 7 days used previously (Table 3.17). 
Table 3.17: Optimisation of 1 mmol scale reaction. 
Entry Reaction 
time (d) 
Yield 53 
(%) 
Yield 52 
(%) 
Total C-H 
activation (%) 
1 7 71 11 82 
2 5 68 9 77 
3 3 38 6 44 
Reactions carried out on 1 mmol scale and 1 M concentration with respect to compound 50 
with 1 eq Ag2CO3, 0.1 eq Pd(OAc)2 and 1.5 eq. I2. 
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The scaleablility of the C-H activation/iodination was probed further and a 
reaction on a 2 mmol scale was carried out. Initial attempts using the 
optimised conditions developed on the 1 mmol scale were low yielding. 
However upon increasing the size of the reaction vessel, a comparable yield 
of 71% was obtained (Table 3.18). This is most likely due to the 
heterogeneous nature of the reaction. As the insoluble by-product AgI is 
formed, it forms a coating on the bottom of the reaction vessel if stirring is 
not adequate. This means that the sparingly soluble Ag2CO3 is unable to 
react at the surface of the reaction. By ensuring efficient stirring the reaction 
was found to successfully scale up to 10 mmol using the optimised 
conditions developed at the 1 mmol scale. In addition, at the larger scale 
where mechanical stirring could be employed, a large reduction in the 
reaction time can be observed (Entry 5). 
Table 3.18: Further scaling of reaction. 
Entry Scale 
(Mmol) 
Reaction time 
(d) 
Yield 53 (%) Yield 52 (%) 
1 1 5 68 9 
2 2 7 67 11 
3 4 7 66 7 
4 10 9 69 8 
a5 10 2 66 9 
aOverhead stirring. Reactions carried out at 1 M concentration with respect to compound 50 
with 1 eq. Ag2CO3, 0.1 eq. Pd(OAc)2 and 1.5 eq. I2. 
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The results presented above in Table 3.18, show that the original problem of 
scaleability of the C-H activation and iodination of alanine derivative 50 
have been overcome. This has principaly been achieved by ensuring efficient 
stirring of the heterogeneous reaction mixture. 
To ensure that the iodination reaction was occurring with no loss of the 
enantiopurity from starting material 50, chiral HPLC conditions were 
developed (Figure 3.4). The conditions were first found for racemic iodide 53 
showing clear separation of the 2 isomers with retention times of (S)-53 33.02 
min, (R)-53 45.22 min. Iodide 53, synthesised from enantiopure starting 
material, was then subjected to the same chiral HPLC conditions and 
pleasingly a peak for only one isomer was observed. To ensure that the peak 
corresponded to one of the isomers observed in the chromatogram of the 
racemic material, a mixture of racemic and enatiopure 53 were subjected to 
the developed HPLC conditions. As expected, 2 peaks were observed, with 
one peak being larger due to the addition of enantiopure 53, thus proving 
that compound 53 has been synthesised enantioselectively in 99% ee. 
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Figure 3.4: Chiral HPLC chromatogram of iodide 53. carried out on a Lux 
3u cellulose-2 column using 20% iPrOH in hexane with a flow rate of 0.7 
mL/min  
3.3.1.2 Amino acid derivatives 
With a successful scaleable method for the C-H activation and subsequent 
iodination of alanine derivative 50 having been developed, the next step was 
to investigate application to other amino acid derivatives. So, phenylalanine, 
leucine and isoleucine were each heated with phthalic anhydride at 160 oC to 
Chiral HPLC chromatogram 
of racemic 53. 
 
Chiral HPLC chromatogram of 
enantiopure 53. 
 
Chiral HPLC chromatogram of 
racemic and enantiopure 53 
combined. 
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give the N-phthaloyl protected products 68, 69 and 70 respectively in good 
yields (Scheme 3.49).  
 
Scheme 3.49: N-Phthaloyl protection of amino acids. 
N-phthaloyl protected amino acids 68, 69 and 70 were converted to the 
corresponding acid chlorides via the reaction with thionyl chloride. 
Subsequent removal of excess thionyl chloride and addition of 8-
aminoquinoline and Hünig’s base furnished the desired products 71, 72 and 
73 in good yields (Scheme 3.50). 
 
Scheme 3.50: Synthesis of 8-aminoquinoline amide amino acid derivatives. 
With compounds 71, 72 and 73 in hand, each was subjected to the C-H 
activation/ iodination conditions developed for alanine derivative 50 on a 1 
mmol scale (Scheme 3.51). Disappointingly none of the desired C-H 
activation product was obtained for any of the starting materials, rather the 
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aromatic iodination products 74, 75 and 76 were isolated in 72, 74 and 75% 
yields respectively. This suggests that the larger side chains of 71, 72, and 73 
compared to alanine derivative 50 hinder the C-H activation and iodination 
reaction, allowing the unwanted aromatic iodination to become the major 
reaction pathway. 
 
Scheme 3.51: Attempted side chain iodination of amino acid derivatives. 
The reactions were repeated in the absence of Pd(OAc)2 to see if the aromatic 
iodination still occurred (Scheme 3.52). This time, aromatic iodinated 
products 74, 75 and 76 were isolated in reduced yield of 27, 31 and 25% 
respectively. This suggests that the presence of Pd(OAc)2 enhances the 
unwanted aromatic iodination via the formation of AcOI as discussed 
previously (Page 59, Scheme 3.25), but some aromatic iodination is still 
occurring.  
 
93 
 
 
Scheme 3.52: Effect of Ag2CO3 and I2 in the absence of Pd(OAc)2 on 
aromatic iodination. 
 To see if C-H activation could be promoted, compounds 71, 72 and 73 were 
subjected to standard aromatic iodination conditions to give products 74, 75 
and 76 respectively in good yields (Scheme 3.53). This blocks the reactive 
para site of the aromatic ring preventing the unwanted side reaction in 
subsequent C-H activation reactions. 
 
Scheme 3.53: Aromatic iodination of amino acid derivatives. 
Compounds 74, 75 and 76 were each treated with catalytic Pd(OAc)2, iodine 
and Ag2CO3 on a 1 mmol scale, but again no  C-H activation products were 
observed and the starting materials were recovered quantitatively (Scheme 
3.54). This suggests that the larger side chains of 74, 75 and 76 were still 
preventing C-H activation under these conditions. 
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Scheme 3.54: Attempted side chain iodination of amino acid derivatives. 
It was decided to focus efforts to achieve C-H activation on 74 and 75 rather 
than 76, as Pd(II) insertion into secondary C-H bond compared to a tertiary 
C-H bond should be easier. In order to check that initial coordination of the 
8-aminoquinoline group to Pd(OAc)2 was occurring, compounds 74 and 75 
were mixed with stoichiometric Pd(OAc)2 in CDCl3 and the resulting 
products observed by 1H NMR spectroscopy (Scheme 3.55). For 
phenylalanine derived compound 74 the -proton shifted from 5.46 to 5.71 
and the CH2 protons shifted from 3.76-3.85 to 4.03 and 4.72. For leucine 
derived compound 75 the -proton shifted from 5.23 to 5.40 and the CH2 
protons shifted from 2.65 and 2.12 to 2.76 and 2.98. Work carried out 
previously in the Jackson group has shown similar changes to the proton 
shifts of alanine derivative 50 due to complexation with Pd(OAc)2.73 This 
suggests that the 8-aminoquinoline group of compounds 74 and 75 is also 
coordinating to Pd(OAc)2. 
 
Scheme 3.55: Coordination of the 8-aminoquinoline group to Pd(II). 
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With evidence in hand that for both compounds 74 and 75 the initial 8-
aminoqinoline-Pd(II) complex was being formed, the reaction mixtures were 
treated with I2 and Ag2CO3 to try and induce the desired C-H activation and 
iodination reaction (Scheme 3.56). However again in neither case was 
evidence for C-H activation observed in the crude 1H NMR spectrum and 
starting materials 74 and 75 were isolated quantitatively. 
 
Scheme 3.56: Attempted side chain iodination of amino acid derivatives. 
As a final attempt to promote C-H activation in compounds 74 and 75, the 
reaction was repeated using the catalytic conditions but this time with 
heating at 62 oC to see if this could overcome the activation barrier and allow 
the desired reaction to take place. Disappointingly, again only starting 
materials 74 and 75 were isolated independently (Scheme 3.57). As many C-
H activation reactions in the literature using these substrates require a high 
temperature to work,66,79-81 heating the reaction to 100 oC in toluene was also 
carried out, but again no reaction took place. 
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Scheme 3.57: Attempted side chain iodination of amino acid derivatives. 
The iodination reactions of 74, 75 and 76 have proved unsuccessful even 
though they been shown to undergo alternative Pd(OAc)2  catalysed C-H 
activation reactions by Corey and co-workers.66  In the case of Corey and co-
workers a Mn(OAc)2 derived Lewis acid was required to facilitate the 
dissociation of the acetate from the palladium to allow for the C-H activation 
to take place. The absence of a Lewis acid to assist the removal of the acetate 
group in the attempted iodination reactions of the more sterically 
demanding substrates 74, 75 and 76 could be one reason why the reaction 
does not occur.  
 
3.3.1.3. Lactic acid derivative 
Having been unsuccessful applying the C-H activation conditions developed 
for alanine derivative 50 to other amino acid compounds, it was thought that 
the analogous lactic acid derivative might be suitable to undergo a similar C-
H activation/iodination process. An acetyl group seemed an obvious starting 
point for protecting the alcohol group, due to its ease of attachment and 
removal, in addition to being stable to the conditions required to create the 
amide functionality. Acetylation was carried out in the presence of pyridine 
and acetic anhydride following a literature procedure (Scheme 3.58).88 The 
crude product underwent vacuum distillation to give the pure product 77 as 
a colourless oil in 60% yield. 
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Scheme 3.58: Acetylation of lactic acid. 
With the acetylated lactic acid 77 in hand, preparation of quinoline amide 
derivative 78 was carried out using the conditions developed for alanine 
derivative 50 to prevent racemisation. Thus compound 77 was converted to 
the corresponding acid chloride and subsequent reaction with the 8-
aminoquinoline in the presence of Hünig’s base gave desired product 78 in 
good yield (Scheme 3.59). 
 
Scheme 3.59: Synthesis of 8-aminoquinoline amide lactic acid derivative. 
 It was decided initially to investigate the C-H activation/ iodination reaction 
with compound 78. The reaction was initially carried out using the 
conditions that had previously been found for alanine derivative 50 (Scheme 
3.60). The 1H NMR spectrum of the crude product showed a 5% conversion 
of 78 to the desired C-H activation product 79 as well as 11% of the 
unwanted aromatic iodination product 80. These products could not be 
isolated separately as they ran with the same Rf value on a silica gel column. 
In addition to compounds 79 and 80, bis-iodide 81 was also formed in 4% 
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yield by 1H NMR spectroscopy and was isolated in 3% yield. The remaining 
material was accounted for by starting material.  
 
Scheme 3.60: Attempted C-H activation of lactic acid derivative 78. 
To try and increase the yield of the reaction an alternative protecting group 
for the alcohol was considered. Yu and co-workers had previously shown a 
TBDMS protecting group to be suitable in C-H activation reactions.70 Both 
the free alcohol and TBDMS protected derivatives 82 and 83 were 
synthesised in good yield (Scheme 3.61).  
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Scheme 3.61: Synthesis of lactic acid derivatives 
Compounds 82 and 83 were each subjected to the catalytic Pd(OAc)2, iodine 
and Ag2CO3 on a 1 mmol scale (Scheme 3.62). In both cases none of the 
desired product was observed but again there was evidence of aromatic 
iodination.   
 
Scheme 3.62: Attempted C-H activation of lactic acid derivatives. 
The iodination of acetyl protected compound 78 was further investigated as 
it had shown the most promising results. The amount of iodine in the 
reaction was increased to see if this would in turn increase the yield of C-H 
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activated product (Table 3.19). The amount of iodine was increased 
incrementally from 1.5 to 3 equivalents, but rather than seeing an increase in 
product 79, only the amount of aromatic iodination increased. 
Table 3.19: Attempted optimisation of C-H activation/Iodination on a 1 
mmol scale. 
Entry Iodine 
(eq.) 
s.m 78 
(%) 
Mono-iodide 
79 (%)a 
Bis-iodide 
81 (%) 
Aromatic 
iodide 80 (%)a 
1 1.5 81 5 3 6 
2 2.0 48 4 6 37 
3 2.5 35 2 8 49 
4 3.0 33 2 8 51 
Reactions carried out on 1 mmol scale and 1 M concentration with respect to compound 78 
with 1 eq Ag2CO3 and 0.1 eq Pd(OAc)2 over 7 days. aBased on 1H NMR of 79 and 80 
combined. 
In order to facilitate the C-H activation reaction it was necessary to prevent 
the unwanted aromatic iodination reaction from occurring. Thus compound  
78 was transformed to 80 in good yield, blocking the para position of the 
aromatic ring by deliberate iodination using PhI(OAc)2 and iodine, in the 
same way as shown previously with the amino acid derivatives (Scheme 
3.63). 
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Scheme 3.63: Aromatic iodination of lactic acid derivative 78. 
Compound 80 was subjected to the C-H activation conditions using 1.5 eq. of 
iodine and desired compound 81 was isolated in 8% yield (Scheme 3.64). The 
fact that with all the experiments the yield had not risen above 10% 
suggested that reaction was not catalytic and that Ag2CO3 was not 
regenerating the active Pd(II) catalyst. The reaction was repeated using a 
stoichiometric amount of Pd(OAc)2 and product 81 was isolated in 46% yield 
suggesting that this may be the case. 
 
Scheme 3.64: Attempted C-H activation of lactic acid derivative 80. 
It became apparent that an alternative to Ag2CO3 was required. The use of 
the more soluble AgOAc was investigated. On subjecting 80 to the modified 
C-H activation conditions, 81 was formed in 9% showing that the reaction 
was still not catalytic (Scheme 3.65). PhI(OAc)2 has been shown in the 
literature to regenerate Pd(OAc)2 in C-H activation iodination reactions on 
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other substrates,70,71 thus it was tried as an alternative to Ag2CO3. On 
applying these modified conditions to 80, this time none of the desired 
product was obtained and only a small amount of the starting material 
remained, according to the crude 1H NMR spectrum. The use of PhI(OAc)2 
had lead to almost complete degradation of the starting material 80. This is 
not completely surprising as the use of PhI(OAc)2 , Pd(OAc)2 and I2 reaction 
conditions with alanine derivative 50 has also been reported to lead to 
decomposition of the starting material, though to a lesser extent.73  
Scheme 3.65: Attempted C-H activation of lactic acid derivative 80. 
3.3.2 Carbon-Oxygen Bond Formation 
The side chain C-H activation/acetoxylation reaction reaction of amino acids 
has previously been demonstrated by Corey and co-workers.66 Following on 
from this, investigations were carried out to see if the reaction conditions 
developed by Corey could be extended to lactic acid derivative 78, with the 
view of providing a route to synthetically useful glyceric acid derivative. 
Initially Corey’s reaction was repeated on alanine derivative 50 to check it 
worked in our hands. The reaction was carried out successfully to give 84, in 
comparable yields to those reported by Corey (Scheme 3.66). However after 
subjection of compound 78 to these reaction conditions the 1H NMR 
spectrum was inconclusive displaying multiple compounds present. This is 
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probably due to the harsh condition of the reaction which was not tolerated 
by the acetyl protecting group present in 78. 
Scheme 3.66: Acetoxylation reaction using conditions developed by Corey 
and co-workers. 
Recently, Daugulis and co-workers have reported the C-H activation and 
acetoxylation of phenylalanine 71 using Pd(OAc)2, PhI(OAc)2 and Ac2O gave 
product 85 in moderate yield and dr. (Scheme 3.67).79 Not only are these 
milder conditions than those employed by Corey but they also use a lower 
catalytic loading of Pd(OAc)2   
 
Scheme 3.67: Acetoxylation of phenylalanine derivative 71 by Daugulis 
and co-workers. 
Following this success, lactic acid derivative 78 was subjected to the 
conditions developed by Daugulis (Scheme 3.68). Pleasingly the 1H NMR 
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spectrum of the crude reaction material showed complete conversion of 
starting material 78 to desired product 86. This was isolated in 96% yield 
providing the first reported example of the catalytic C-H activation of a lactic 
acid derivative. 
 
Scheme 3.68: Acetoxylation of lactic acid derivative 78. 
Continuing from this the C-H activation/ acetoxylation conditions were 
applied to TBDMS protected derivative 83 with the view of producing 
product 87 with two different protecting groups present (Scheme 3.69). 
However on carrying out the reaction only starting material was 
quantitatively retrieved and no evidence of C-H activation was observed.  
 
Scheme 3.69: Attempted acetoxylation of lactic acid derivative 83. 
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3.3.3 Reactions with Iodoalanine 53. 
3.3.3.1 Negishi cross-coupling reaction 
Much of the previous work in the Jackson group has focused on the 
preparation of enantiomerically pure non-natural amino acids via side chain 
modification.18 Alkyl iodides derived from natural amino acids provide 
precursors to key organometallic intermediates required for carbon-carbon 
bond forming reactions. Whilst powerful, this approach is restricted by the 
range of suitable starting materials available.  It would be a considerable 
advance if the range of available alkyl iodides could be increased.  
With iodoalanine 53 in hand, it was decided to subject the compound to the 
standard cross coupling conditions developed in the Jackson group for the 
synthesis of phenylalanine derivatives (Scheme 3.70).18 The zinc was 
activated using iodine in DMF and its insertion into 53 to form organozinc 
reagent 88 was monitored by TLC. Catalytic Pd2dba3 and SPhos were then 
added, in addition to iodobenzene. Disappointingly none of desired product 
89 was observed by 1H NMR spectroscopy. Following column 
chromatography, only compound 50 was isolated indicating that protonation 
of the organozinc reagent had occurred. 
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Scheme 3.70: Attempted Negishi cross-coupling of organozinc reagent 88 
with iodobenzene. 
Attempts to trap organozinc reagent 88 were made. The zinc insertion was 
monitored by TLC until completion at which point the solution of 88 was 
removed from the excess zinc and quenched with iodine (Scheme 3.71). 
Again protonated product 50 was the only compound observed opposed to 
the desired regenerated iodoalanine 53, suggesting rapid protonation of 88. 
 
Scheme 3.71: Attempted iodine quench of organozinc reagent 88. 
On examination of the structure of the organozinc reagent it can be seen that 
this rapid protonation may be due to the intramolecular protonation of the 
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carbon-zinc bond by the amide proton (Scheme 3.72). This is facilitated by 
the fact the organozinc reagent is set up to form a favourable five-membered 
ring transition state. A similar process has been reported previously in the 
Jackson group, with the self protonation of -benzamido alkylzinc iodides.89 
This was studied kinetically and proven to be a first order reaction. 
 
 
Scheme 3.72: Intramolecular protonation of the organozinc reagent. 
 
Work recently carried out by Ashley Robinson in the Jackson group, has 
shown that it is possible to cross-couple organozinc reagent 91 derived from 
methyl ester 90 with a range of aryl halides in moderate to good yields 
(Scheme 3.73).73 This supports the suggestion that the unwanted protonation 
is due to the NH proton of the amide. 
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Scheme 3.73: Cross-coupling of organzinc reagent 91 with aryl halides 
carried out previously in the Jackson group. 
A method has recently been developed in the group for the cross-coupling of 
proline derivatives.90 Under standard conditions the organozinc reagent 
undergoes rapid elimination to give alkene product 93 as the major product 
(Scheme 3.74). 
 
Scheme 3.74: Elimination of -animoalkylzinc reagent. 
 In order to reduce this unwanted elimination a new cross-coupling method 
was developed (Scheme 3.75).90 All reagents apart from proline iodide 92 are 
added to a solution of activated zinc. Compound 92 is then added in 
portions (10 mol%) over a period of time at low temperatures. This means 
that as the organozinc reagent is formed it can react directly with the 
palladium species formed from the oxidative addition step. Essentially the 
organozinc reagent is trapped in situ reducing the chance of undergoing 
elimination.  
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Scheme 3.75: Negishi cross-coupling of proline derivatives previously 
carried out in the Jackson group. 
Although elimination is not a problem for organozinc reagent 88, it was 
thought that the in situ trapping method could be used to prevent total 
protonation. However on carrying out this experiment, protonated product 
50 was all that was formed, suggesting that degradation of the organozinc 
reagent is faster than transmetallation (Scheme 3.76). 
 
Scheme 3.76: Attempted Negishi cross-coupling of organzinc reagent 88 
with iodobenzene. 
As the proton on the nitrogen evidently seemed to be the problem, the next 
course of action was to try to remove it. A cross-coupling reaction was 
carried out with the addition of 1 eq. of Hünig’s base to see if this would 
suppress the unwanted protonation of the zinc reagent (Scheme 3.77). 
However, this only led to a mixture of protonated product 50 and 
dehydroalanine 94 indicating that  the base simply eliminates HI. 
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Scheme 3.77: Attempted Negishi cross-coupling of organzinc reagent 88 
with iodobenzene. 
As the use of base was unsuitable, the idea of temporarily protecting the 
nitrogen was considered. Introduction of the TMS protection group seemed 
suitable as the reaction conditions for addition (refluxing with 
bis(trimethylsilyl)acetamide in CH2Cl2) were mild and it could easily be 
removed in work-up on completion of the cross-coupling reaction. Thus 
compound 53 and an excess of BSA were refluxed in CH2Cl2 for 6 hours 
(Scheme 3.78). 1H NMR spectroscopy of the resulting compound showed the 
disappearance of the NH proton and a shift in the position of the proton 
suggesting desired compound 95 had been formed.  
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Scheme 3.78: TMS protection of the 8-aminoquinoline amide. 
Having removed the CH2Cl2, crude material 95 was transformed to 
organozinc reagent 97 and subjected to the cross-coupling conditions, but as 
before only protonated material 50 was isolated (Scheme 3.79). It was 
thought that the protic by-product 96 may also cause protonation of the 
organozinc reagent so the reaction was repeated, this time distilling off the 
excess BSA and by-product (50 oC/0.1 mbar) before compound 95 was 
subjected to the cross-coupling conditions. Disappointingly as before only 
protonated product 50 was formed, suggesting that the TMS protecting 
group is not stable enough to withstand the cross-coupling reaction.  Overall 
these reactions have shown that compound 53 is not suitable for Negishi 
cross-coupling reactions. 
 
112 
 
 
Scheme 3.79: Attempted Negishi cross-coupling of organozinc reagent 97 
and iodobenzene. 
 
3.3.3.2 Deprotection of compound 53 
Compound 53 has been shown unsuitable for Negishi cross-coupling 
reactions due to the acidity of the NH proton. Conversely the methyl ester 
derivative 90 has successfully been converted into the respective organozinc 
reagent and been coupled with a range of aryl halides.73 Thus it would be of 
synthetic use if 53 could be transformed to 90 by deprotection of the 8-
aminoquinoline group. 
Daugulis and co-workers have successfully deprotected the 8-
aminoquinoline group in a range of phenylalanine derivatives using BF3.Et2O 
in MeOH to give the corresponding methyl ester products.79 Compound 53 
was therefore subjected to the same conditions; however the desired methyl 
ester product was not formed (Scheme 3.80). The crude 1H NMR spectrum 
showed the presence of several compounds but the major product isolated 
was eliminated methyl ester 98. This suggested that the deprotection did 
work to some extent but it is likely the addition of NEt3 used to break up the 
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borane complex caused the elimination of HI.  The reaction was repeated this 
time using a K2CO3 wash rather than adding NEt3. The crude 1H NMR 
spectrum showed only a small amount of product 98 due to elimination of 
HI by the base work-up and the presence of new diastereotopic protons. 
However on carrying out column chromatography none of the desired 
product was isolated suggesting that K2CO3 was not strong enough to break 
up the borane complex. 
 
Scheme 3.80: Removal of the 8-aminoquinoline group using conditions 
employed by Daugulis and co-workers.  
It was apparent that an alternative method was needed which did not 
require the use of base. Chatani and co-workers have shown that refluxing 
aliphatic acid derivatives in methanolic HCl deprotects the 8-aminoquinoline 
group and gives the corresponding methyl ester (Scheme 3.81).81 Pleasingly 
applying these conditions to compound 53 gave the desired product 90 in 
65% yield. 
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Scheme 3.81: Removal of the 8-aminoquinoline group using conditions 
employed by Chatani and co-workers. 
This reaction means that a route from alanine to phenylalanine derivatives 
has now been established, using the methodology described in this thesis. 
3.3.3.3 -Lactam formation. 
It was envisaged that iodoalanine 53 could be used to form the -lactam 
derivative 99 in the presence of base (Scheme 3.82). However due to the 
acidity of the proton, the amount and strength of the base would have to 
be carefully considered to limit the formation of dehydroalanine 94 (Table 
3.20). Initial results using dry DMF with a range of bases saw none of desired 
product 99 and small amounts of 94. However on using ‘wet’ DMF with 
K2CO3, 73% yield of compound 99 was obtained (Entry 4). This presumably is 
due to small amounts of K2CO3 being solubilised by the water present in the 
DMF. 
 
Scheme 3.82: -Lactamisation of 53 
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Table 3.20: Effects of varying the base on the -Lactamisation of 53. 
Entry  Base (1.1 eq.)  Solvent  Yield 99 (%)  Yield 94 (%)  
1  NaHCO3  Dry DMF  0  Trace  
2  iPr2EtN  Dry DMF  0  13  
3  K2CO3 Dry DMF  0  9  
4 K2CO3 DMF  85  8  
5 NaHCO3 DMF 0 Trace 
6 NaH DMF 11 32 
Reactions carried out on an 0.5 mmol scale and 0.1 M concentration with respect to 
compound 53 at rt for 6h. 
In order to ensure reproducibility of results the amount of H2O in the DMF 
required that allowed the lactamisation to occur whilst limiting the 
unwanted elimination reaction was investigated (Table 3.21). At higher 
water contents, lactamisation still occurred but the amount of eliminated 
product 100 also increased. It was found that reducing the water content to 
0.05% in DMF gave the product 99 in 82% yield (Entry 4).  
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Table 3.21: -Lactamisation of 53. 
Entry  H2O in DMF 
(%) 
1H NMR 
Yield 99 (%)  
1H NMR 
Yield 94 (%)  
1  10 66 34  
2  1 77  23  
3  0.1 86  14  
4 0.05 91 (82%)a 9  
aIsolated yield. Reactions carried out on an 0.5 mmol scale and 0.1 M concentration with 
respect to compound 53 at rt for 6h. 
 
There was concern that due to the presence of product 94 that there may be 
some epimerisation of product 99. To ensure that the reaction was occurring 
with no loss of the enantiopurity from starting material 53, chiral HPLC 
conditions were developed (Figure 3.5). The conditions were first found for 
racemic -lactam 99 showing clear separation of the 2 isomers with retention 
times of (R)-99 41.33 min, (S)-99 49.89 min. -lactam 99, synthesised from 
enantiopure starting material, was then subjected to the same chiral HPLC 
conditions and pleasingly a peak for only one isomer was observed. To 
ensure that the peak corresponded to one of the isomers observed in the 
chromatogram of the racemic material, a mixture of racemic and enatiopure 
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99 were subjected to the developed HPLC conditions. As expected, 2 peaks 
were observed, with one peak being larger due to the addition of enatiopure 
99, thus proving that 99 has been synthesised enantioselectively in 98% ee. 
    
                          
 
 
 
Figure 3.5: Chiral HPLC of -lactam 99. carried out on a Lux 3u cellulose-2 
column using 25% iPrOH in hexane with a flow rate of 1 mL/min  
 
Chiral HPLC chromatogram 
of racemic 99. 
 
Chiral HPLC chromatogram of 
enantiopure 99. 
 
Chiral HPLC chromatogram of 
racemic and enantiopure 99 
combined. 
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With -lactam 99 in hand it was an obvious precursor to a -aminoalanine 
derivative via a ring opening reaction, giving an indirect route to C-N bond 
formation. Thus compound 99 was refluxed in methanolic acid overnight to 
give the desired product 100 in 79% yield (Scheme 3.83). 
 
Scheme 3.83: Ring opening of the -lactam.  
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3.4 Conclusion 
The Pd(OAc)2 catalysed C-H activation and iodination of alanine derivative 
50 has been successfully carried out on a 10 mmol scale. Application of the 
C-H activation iodination conditions to other amino acid derivatives was 
unsuccessful with unwanted aromatic iodination being the main product. 
Subjecting the aromatic iodinated amino acid derivatives to the same 
conditions still did not yield any of the desired products. This suggests that 
the increased size of the side chains in these amino acids compared to 
alanine is preventing the C-H activation from occurring. 
The side chain iodination of lactic acid derivative 80 has shown promise with 
the desired product being formed in 8%. The reaction has proved not to be 
occurring catalytically, showing that Ag2CO3 is not suitable for the 
regeneration of the active Pd(II) catalyst in this instance. Initial investigations 
have been made into discovering an alternative to Ag2CO3 in order to make 
the reaction catalytic, however one has yet to be found.  
Lactic acid derivative 78 has successfully undergone a C-H activation and 
acetoxylation reaction to give the glyceric acid derivative 86 in excellent 
yield. This provides the first reported example of a catalytic C-H activation 
on a lactic acid derivative. 
The Negishi cross-coupling reaction of iodoalanine derived organozinc 
reagents with phenyl iodide has been unsuccessful. The reason for this is the 
presence of the NH proton which causes rapid intramolecular protonation of 
the organozinc reagent before transmetallation onto the palladium can occur. 
Attempts to remove the NH proton by TMS protection also did not lead to 
any of the desired cross-coupled product. A way around this is the use of the 
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iodoalanine methyl ester 90 which has previously been shown to undergo 
cross-coupling reactions with a range of aryl halides. The 8-aminoquinoline 
group of compound 53 was deprotected to give 90 in 65% yield. 
Iodoalanine 53 has also been transformed into the -lactam 99 in good yield 
when subjected to K2CO3 in 0.05% H2O in DMF. The water allows a small 
amount of K2CO3 to go in solution and under these dilute conditions, the 
formation of the -lactam is favoured over dehydroalanine94. -lactam 99 
was successfully ring opened to afford the -aminoalanine derivative 100 in 
good yield.  
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4. Experimental 
 
All moisture/air sensitive reactions were conducted under a nitrogen 
atmosphere in flame-dried or oven-dried glassware. All reagents used were 
purchased from commercial sources and used without further purification. 
Water is demineralised water. All solvents used were HPLC grade or 
distilled. Petroleum ether refers to the fraction which boils in the range 40-60 
°C. Solvent evaporation under reduced pressure was performed using a 
Büchi rotary evaporator connected to a membrane pump. Purification was 
performed using flash chromatography apparatus and pressurised air, on 
silica gel for flash chromatography from BDH Lab or Davisil Fluorochem. 
Thin layer chromatography was performed using pre-coated plates (0.2 mm, 
Merck DC-alufolien Kieselgel 60 F254), and compounds visualised by UV light 
(254 nm), ninhydrin solution (5% in MeOH) or KMnO4.  
13C and 1H Nuclear magnetic resonance (NMR) spectra were recorded using 
a Bruker AMX 400 at room temperature. Chemical shifts are referenced to 
residual solvent and are expressed in parts per million. 1H NMR spectra are 
reported in the form: δH (integration, multiplicity, J value, assignment). 
Coupling constants are given in Hertz, and are corrected to the nearest 0.5 
decimal place. 13C NMR spectra were recorded at 101 MHz. High-resolution 
mass spectra were recorded using a Kratos MS 25 or MS 80 for electro impact 
(EI) or a MicroMass LCT operating in Electrospray (ES) mode. Infra-red 
spectra were recorded on a Perkin Elmer Paragon 100 FTIR 
spectrophotometer (νmax in cm-1) as thin films using NaCl plates. 
Wavenumbers are quoted to the nearest whole number. Melting points were 
determined using a Linkham HFS91 heating stage, used in conjunction with 
a TC92 controller and are uncorrected. Optical rotations were determined 
using an AA-10 Automatic Polarimeter, at 589nm.  Resolution between 
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enantiomers was achieved using a Beckman system fitted with a Lux x 3u 
cellulose-2-column (250 mm x 4.60 mm i.d.) as the stationary phase with a 
mixture of n-hexane: isopropanol as the mobile phase at ambient 
temperature and detection by UV absorbance at 254 nm. 
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4.2 Chapter 2 Experimental 
4.2.1  L-Serine methyl ester hydrochloride, 9 
 
 
 
A 250 cm3, three-necked round bottomed flask, containing a magnetic stirrer 
bar, was equipped with a dropping funnel, reflux condenser and glass 
stopper. The dropping funnel was charged with acetyl chloride (46 mL, 647 
mmol) which was then added dropwise to MeOH (300 mL) at 0 °C for 10 
min. L-serine (24.022 g, 229 mmol) was then added to the solution which was 
stirred for a further 5 min at 0 °C. The reaction was then heated at reflux for 2 
h. After the solution had cooled to rt, the solvent was removed under 
reduced pressure to yield the crude L-serine methyl ester in quantative yield 
as a white solid (34.66 g); [α]D25 +5.0 (c 2.0, MeOH), lit. value [α]D25 +5.0 (c 2.0, 
MeOH);29 δH (400 MHz, D2O) 3.73 (3H, s, OCH3), 3.88 (1H, dd, J 12.5, 4.0, 
CH2), 3.97 (1H, dd, J 12.5, 4.0, CH2), 4.15 (1H, t, J 4.0, CH); δC (101 MHz, D2O) 
53.7, 54.7, 59.2, 168.9. Spectroscopic data is consistent with that previously 
reported.29 
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4.2.2  N-(tert-butoxycarbonyl)-L-serine methyl ester, 10 
 
 
 
Crude L-serine methyl ester hydrochloride 9 (34.66 g, 223 mmol) was added 
to water (150 mL) at rt and left stirring to dissolve. Once fully dissolved, 
K2CO3 (30.82g, 223 mmol) and Boc2O (49.13g, 223 mmol) were added and the 
solution was left to stir overnight. The product was then extracted with Et2O 
and dried with MgSO4. The solvent was then removed under reduced 
pressure to yield the crude N-(tert-butoxycarbonyl)-L-serine methyl ester as a 
thick, colourless oil (35.17g, 75% crude yield); [α]D25 -18.1 (c 4.1, MeOH), lit. 
value -19.1 (c 4.07, MeOH);91 δH (400 MHz, CDCl3) 1.48 (9H, s, C(CH3)), 3.82 
(3H, s, OCH3), 4.03–3.88 (2H, m, CH2), 4.42 (1H, s, CH), 5.45 (1H, s, NH); δC 
(101 MHz, CDCl3) 28.7, 53.0, 56.1, 63.8, 80.7, 156.2, 171.8. Spectroscopic data 
is consistent with that previously reported.91  
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4.2.3 N-(tert-butoxycarbonyl)-O-(p-toluenesulfonyl)- L-serine methyl ester, 
11 
 
 
Crude N-(tert-butoxycarbonyl)-L-serine methyl ester 10 (26.10 g, 119 mmol) 
was dissolved in dry CH2Cl2 (200 mL). 4-DMAP (0.71 g, 5.90 mmol), 
Me3N.HCl (1.10 g, 12.0 mmol) and p-TsCl (22.70 g, 119 mmol) were added to 
the solution at 0 °C. A dropping funnel was charged with Et3N (17 mL, 119 
mmol) dissolved in dry CH2Cl2 (50 mL) which was then added dropwise to 
the solution at 0 °C for 40 min. The resulting white slurry was stirred for 2 h 
at 0 °C before it was poured onto a mixture of ice (100 mL), water (100 mL) 
and 2 M HCl (50 mL). The aqueous layer was washed with CH2Cl2 (100 mL). 
The combined organic extracts were washed with brine (60 mL), dried over 
MgSO4 and the solvent removed under reduced pressure to yield the crude 
product as a white solid (35.89 g). The solid was dissolved in hot Et2O (140 
mL) and filtered to remove the insoluble white solid. The filtrate was 
allowed to cool to room temperature before being cooled to 0 °C. 
Crystallisation from petroleum ether (250 mL) at -20 °C overnight gave white 
crystals of N-(tert-butoxycarbonyl)-O-(p-toluenesulfonyl)-L-serine methyl 
ester (21.69 g, 53%): m.p. 70-72 °C, lit. value 74-76 °C;92 [α]D25 +2.2 (c 2.0, 
MeOH), lit. value [α]D25 +3.0 (c 2.0, MeOH);92 δH (400 MHz, CDCl3) 1.44 (9H, s, 
C(CH3)3), 2.48 (3H, s, CH3), 3.72 (3H, s, OCH3), 4.31 (1H, dd, J 10.0, 3.0, CH2), 
4.42 (1H, dd, J 10.0. 3.0, CH2), 4.57–4.48 (1H, m, CH), 5.32 (1H, d, J 8.0, NH), 
7.38 (2H, d, J 8.0, ArH),  7.79 (2H, d, J 8.0, ArH); δC (101 MHz, CDCl3) 21.7, 
28.2, 52.9, 53.0, 69.5, 80.5, 128.0, 130.0, 132.4, 145.2, 155.0, 169.0. Spectroscopic 
data is consistent with that previously reported.92 
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4.2.4  N-(tert-butoxycarbonyl)-3-iodo-L-alanine methyl ester, 12  
 
 
 
N-(tert-butoxycarbonyl)-O-(p-toluenesulfonyl)-L-serine methyl ester 11 (21.69 
g, 65.93 mmol) was dissolved in acetone (160 mL) whilst being stirred. NaI 
(11.85 g, 79.10 mmol) was added and the flask was covered in aluminium 
foil. After stirring for 3 d, further NaI (2.96 g, 19.77 mmol) was added in one 
portion and the reaction was stirred for 1 d. The orange slurry was filtered 
through a sintered glass funnel, and the orange solid isolated was washed 
with acetone until the solid was colourless. The flask containing the filtrate 
was covered with aluminium foil to exclude light and the solvent was 
removed under reduced pressure at 0 °C. The solution was warmed to room 
temperature and the acetone was allowed to evaporate, producing a dark 
orange oil. The oil was then partitioned between Et2O (150 mL) and 1 M 
Na2S2O3 (60 mL). The organic layer was washed with Na2S2O3 (40 mL) and 
brine (50 mL), dried over MgSO4 and the solvent removed under reduced 
pressure to yield the crude product as a pale yellow solid (16.95 g). The solid 
was dissolved in hot 40/60 petroleum ether (50 mL) before being cooled to 0 
°C. The solution was then cooled further to -20 °C overnight, yielding N-
(tert-butoxycarbonyl)-3-iodo-L-alanine methyl ester as a pale yellow solid. 
This solid was washed with cold petroleum ether, before being air dried and 
ground down to give a pale yellow powder (13.52 g, 59%); m.p. 41-45 °C, lit. 
value 45-47 °C;92  [α]D25 -3.6, c 3.0, MeOH (lit. -3.7, c 3.0, MeOH);92 δH (400 
MHz, CDCl3) 1.48 (9H, s, C(CH3)3), 3.64–3.54 (2H, m, CH2I), 3.82 (3H, s, 
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OCH3), 4.58–4.50 (1H, m, CH), 5.38 (1H, d, J = 7.0, NH); δC (101 MHz, CDCl3) 
7.9, 28.3, 53.0, 53.7, 80.5, 154.8, 170.1. Spectroscopic data is consistent with 
that previously reported.92  
 
General cross-coupling Method A: 
Zinc dust (190 mg, 3 mmol) was added to a flame dried, nitrogen purged 
side arm round bottom flask.  Dry DMF (1 mL) was added via syringe 
followed by a catalytic amount of iodine (40 mg, 0.15 mmol).  A colour 
change of the DMF was observed from colourless to yellow and back again.  
Iodoalanine 12 (329 mg, 1 mmol) was added immediately followed by a 
catalytic amount of iodine (40 mg, 0.15 mmol).  The solution was stirred at rt 
and gave a noticeable exotherm.  When the solution had cooled Pd2dba3 (22 
mg, 0.025 mmol), phosphine ligand (0.05 mmol) and aryl halide (1.3 mmol) 
were added to the flask and left to stir at rt overnight, under positive 
pressure of nitrogen.  The crude reaction mixture was applied directly to a 
silica gel column to afford the purified cross-coupled product. 
 
General cross-coupling Method B: 
Zinc dust (190 mg, 3 mmol) was added to a flame dried, nitrogen purged 
side arm round bottom flask.  Dry DMF (1 mL) was added via syringe 
followed by a catalytic amount of iodine (40 mg, 0.15 mmol).  A colour 
change of the DMF was observed from colourless to yellow and back again.  
Iodoalanine 12 (329 mg, 1 mmol) was added immediately followed by a 
catalytic amount of iodine (40 mg, 0.15 mmol).  The solution was stirred at rt 
and gave a noticeable exotherm.  In a separate flame dried nitrogen purged 
flask Pd2dba3 (11 mg, 0.0125 mmol), was added followed by dry DMF (0.5 
mL).  In a separate, flame dried nitrogen purged flask, phosphine ligand 
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(0.025 mmol) was added followed by dry DMF (0.5 mL).  Once the zinc 
insertion has cooled the palladium solution (100 µL, 0.0025 mmol) and 
phosphine ligand solution (100 µL, 0.005 mmol) were added via syringe 
followed by aryl halide (1.3 mmol).  The reaction was allowed to stir at rt 
overnight under positive pressure of nitrogen.  The crude reaction mixture 
was applied directly to a silica gel column to afford the purified cross-
coupled product. 
 
4.2.5 (S)-methyl 2-(tert-butoxycarbonylamino)-3-(2-nitrophenyl)-
propanoate, 13 
 
 
 
Following a variation of general cross-coupling Method A, (after zinc 
insertion the zinc was allowed to settle and the liquid removed into a 
separate flame dried, nitrogen purged side arm round bottom flask) using 
XPhos (24 mg, 0.05 mmol) and 1-iodo-2-nitrobenzene (323 mg, 1.3 mmol) 
gave, after purification by silica gel column (20% EtOAc in petrol) the title 
compound (195 mg, 79%) as a yellow solid. 
Following a variation of general cross-coupling Method B, (after zinc 
insertion the zinc was allowed to settle and the liquid removed into a 
separate flame dried, nitrogen purged side arm round bottom flask) using 
XPhos (2.4 mg, 0.005 mmol) and 1-iodo-2-nitrobenzene (323 mg, 1.3 mmol) 
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gave, after purification by silica gel column (20% EtOAc in petrol) gave the 
title compound (191 mg, 59%) as a yellow solid. 
m.p. 78-80 oC, lit. value 83-84 oC;  Rf 0.17 (20% EtOAc in petrol); [α]D22 +27.8 (c 
0.18, CH2Cl2), lit. value [α]D22 +42.7 (c 0.19, CH2Cl2);18 δH (400 MHz, CDCl3) 
1.35 (9H, s, C(CH3)3), 3.24 (1H, dd, J 13.5 and 8.5, CH2), 3.55 (1H, dd, J 13.5 
and 8.5, CH2), 3.74 (3H, s, OCH3), 4.69 (1H, dd, J 13.5 and 8.5, CH), 5.24 (1H, 
d, J 8.0, NH), 7.41 (2H, dd, J 12.0 and 8.0, ArH), 7.56 (1H, t, J 8.0 ArH), 7.96 
(1H, d, J 8.0, ArH); δC (101 MHz, CDCl3) 28.2, 35.6, 52.6, 54.0, 80.0, 125.0, 
128.1, 131.8, 132.9, 133.0, 149.7, 155.0, 172.0. Spectroscopic data is consistent 
with that previously reported.18  
 
 4.2.6 (S)-methyl 2-(tert-butoxycarbonylamino)-3-(3-nitrophenyl)-
propanoate, 14 
 
 
 
Following a variation of general cross-coupling Method A, (after zinc 
insertion the zinc was allowed to settle and the liquid removed into a 
separate flame dried, nitrogen purged side arm round bottom flask) using 
XPhos (24 mg, 0.05 mmol) and 1-iodo-3-nitrobenzene (323 mg, 1.3 mmol) 
gave, after purification by silica gel column (20% EtOAc in petrol) the title 
compound (178 mg, 84%) as a yellow solid. 
Following a variation of general cross-coupling Method B, (after zinc 
insertion the zinc was allowed to settle and the liquid removed into a 
separate flame dried, nitrogen purged side arm round bottom flask) using 
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XPhos (2.4 mg, 0.005 mmol) and 1-iodo-3-nitrobenzene (324 mg, 1.3 mmol) 
gave, after purification by silica gel column (20% EtOAc in petrol) the title 
compound (217 mg, 67%) as a yellow solid. 
m.p. 102-103 oC; Rf 0.16 (20% EtOAc in petrol); [α]D22 +48.7 (c 1.0, CHCl3), lit. 
value [α]D22 +49.5 (c 0.19, CH2Cl2);18 δH (400 MHz, CDCl3) 1.43 (9H, s, 
C(CH3)3), 3.13 (1H, dd, J 14.0 and 6.0, CH2), 3.31 (1H, dd, J 14.0 and 6.0, CH2), 
3.77 (3H, s, OCH3), 4.64 (1H, dd, J 13.5 and 6.5, CH), 5.12 (1H, d, J 7.5, NH), 
7.54-7.46 (2H, m, ArH), 8.02 (1H, s, ArH), 8.10-8.16 (1H, m, ArH); δC  (101 
MHz, CDCl3) 28.2, 38.1, 52.5, 54.2, 80.3, 122.1, 124.3, 130.3, 135.6, 138.4, 148.3, 
154.9, 171.6. Spectroscopic data is consistent with that previously reported.18  
 
4.2.7 (S)-methyl 2-(tert-butoxycarbonylamino)-3-(4-nitrophenyl)-
propanoate, 15 
 
 
 
Following a variation of general cross-coupling Method A, (after zinc 
insertion the zinc was allowed to settle and the liquid removed into a 
separate flame dried, nitrogen purged side arm round bottom flask) using 
XPhos (24 mg, 0.05 mmol) and 1-iodo-4-nitrobenzene (323 mg, 1.3 mmol) 
gave, after purification by silica gel column (20% EtOAc in petrol) the title 
compound (240 mg, 83%) as a yellow solid. 
Following a variation of general cross-coupling Method B, (after zinc 
insertion the zinc was allowed to settle and the liquid removed into a 
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separate flame dried, nitrogen purged side arm round bottom flask) using 
XPhos (2.4 mg, 0.005 mmol) 1-iodo-4-nitrobenzene (324 mg, 1.3 mmol), after 
purification by silica gel column (20% EtOAc in petrol) gave the title 
compound (172 mg, 74%) as a yellow solid. 
m.p. 99-101 oC, lit. value 95-97 oC; Rf 0.15 (20% EtOAc in petrol); [α]D21 +43.5 (c 
1.06, CH2Cl2), lit. value [α]D20 +30.4 (c 1.06, CH2Cl2);18 δH (400 MHz; CDCl3) 
1.39 (9H, s, (CH3)3), 3.11 (1H, dd, J 13.5, 6.5, CH2), 3.27 (1H, dd, J 13.5, 6.0, 
CH2), 3.72 (3H, s, OCH3), 4.62 (1H, dd, J 13.5, 6.5, CH), 5.16 (1H, d, J 8.0, NH), 
7.31 (2H, d, J 8.5, ArH), 8.14 (2H, d, J 8.5, ArH); δC (101 MHz, CDCl3) 28.2, 
38.4, 52.5, 54.1,  80.3, 123.6, 130.2, 144.1, 147.1, 154.9, 171.6. Spectroscopic data 
is consistent with that previously reported.18  
 
4.2.8 (S)-methyl 2-(tert-butoxycarbonylamino)-3-phenylpropanoate, 16 
 
 
 
Following general cross-coupling Method A using SPhos (21 mg, 0.05 mmol) 
and iodobenzene (145 µL, 1.3 mmol) gave, after purification by silica gel 
column (5% EtOAc in toluene) gave the title compound (218 mg, 78%) as a 
yellow oil. 
Following general cross-coupling Method A using iodobenzene (145 µL, 1.3 
mmol) gave, after purification by silica gel column (5% EtOAc in toluene) the 
title compound (223 mg, 84%) as a yellow oil. 
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Following general cross-coupling Method B using SPhos (2.1 mg, 0.005 
mmol) and   iodobenzene (145 µL, 1.3 mmol) gave, after purification by silica 
gel column (5% EtOAc in toluene) the title compound (220 mg, 79%) as a 
yellow oil.  
Following general cross-coupling Method B using XPhos (2.4 mg, 0.005 
mmol) and  iodobenzene (145 µL, 1.3 mmol) gave, after purification by silica 
gel column (5% EtOAc in toluene) the title compound (235 mg, 81%) as a 
yellow oil.  
Rf 0.5 (30% EtOAc in petrol); [α]D22 +46.0 (c 1.0, CHCl3) , lit. value [α]D22 +47.0 
(c 1.0, CHCl3);18 δH (400 MHz, CDCl3) 1.44 (9H, s, C(CH3)3), 3.10 (2H, dd, J 14.0 
and 6.0, CH2), 3.75 (3H, s, OCH3), 4.61 (1H, dd, J 14.0 and 6.0, CH), 5.00 (1H, 
d, J 8.0, NH), 7.15 (2H, d, J 7.0, ArH), 7.36-7.23 (3H, m, ArH); δC (101 MHz, 
CDCl3) 18.6, 27.3, 28.3, 38.3, 52.2, 54.4, 79.9, 127.0, 128.5, 129.3, 136.1, 155.1, 
172.3. Spectroscopic data is consistent with that previously reported.18  
 
4.2.9 (S)-methyl 2-(tert-butoxycarbonylamino)-3-(2-methoxyphenyl)- 
propanoate, 17 
 
 
 
Following general cross-coupling Method A using XPhos (24 mg, 0.05 mmol) 
and 2-iodoanisole (169 µL, 1.3 mmol) gave, after purification by silica gel 
column (3% EtOAc in toluene) the title compound (213 mg, 69%) as an 
orange oil. 
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Following general cross-coupling Method B using XPhos (2.4 mg, 0.005 
mmol) and 2-iodoanisole (169 µL, 1.3 mmol) gave, after purification by silica 
gel column (3% EtOAc in toluene) the title compound (148 mg, 48%) as an 
orange oil. 
 
Rf 0.64 (30% EtOAc in toluene); [α]D21 +13.6 (c 0.74, CH2Cl2) lit. value [α]D20 
+14.9 (c 0.68, CH2Cl2);18 δH (400 MHz; CDCl3) 1.39 (9H, s, (CH3)3), 3.13-3.02 
(2H, m, CH2), 3.71 (3H, s, OCH3), 3.84 (3H, s, ArOCH3), 4.52 (1H, dd, J 13.5, 
7.5, CH), 5.26 (1H, d, J 7.5, NH), 6.89 (2H, dd, J 16.0, 8.0, ArH), 7.10 (1H, dd, J 
7.5, 1.5, ArH), 7.27-7.21 (1H, m, ArH); δC (101 MHz; CDCl3) 28.3, 32.8, 52.0, 
54.0, 55.3, 79.5, 110.4, 120.6, 124.7, 128.4, 131.1, 155.3, 172.9. Spectroscopic 
data is consistent with that previously reported.18 
4.2.10 (S)-methyl 2-(tert-butoxycarbonylamino)-3-(3-methoxyphenyl)- 
propanoate, 18 
 
 
 
Following general cross-coupling Method A using XPhos (24 mg, 0.05 mmol) 
and 3-iodoanisole (155 µL, 1.3 mmol) gave, after purification by silica gel 
column (3% EtOAc in toluene) the title compound (216 mg, 75%) as an 
orange oil. 
Following general cross-coupling Method B using XPhos (2.4 mg, 0.005 
mmol) and 3-iodoanisole (155 µL 1.3 mmol) gave, after purification by silica 
gel column (3% EtOAc in toluene) the title compound (232 mg, 70%) as an 
orange oil. 
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Rf 0.46 (20 % EtOAc in toluene); [α]D22 +43.5 (c 1.0, CHCl3), lit. value [α]D22 
+46.1 (c 1.02, CHCl3);18 δH  (400 MHz, CDCl3) 1.43 (9H, s, C(CH3)3), 3.07 (2H, 
dd, J 14.0 and 6.0, CH2), 3.73 (3H, s, OCH3), 3.79 (3H, s, OCH3), 4.59 (1H, dd, J 
14.0 and 6.0, CH), 5.04 (1H, d, J 8.0, NH), 6.68 (1H, d, J 2.0, ArH), 6.72 (1H, d, 
J 7.5, ArH), 6.80 (1H, dd, J 8.0 and 2.0, ArH), 7.21 (1H, t, J 8.0, ArH); δC  (101 
MHz, CDCl3) 28.3, 38.3, 52.2, 54.4, 55.1, 79.9, 112.5, 115.0, 121.6, 129.5, 137.5, 
155.1, 159.7, 172.3. Spectroscopic data is consistent with that previously 
reported.18 
 
4.2.11 (S)-methyl 2-(tert-butoxycarbonylamino)-3-(4-methoxyphenyl)- 
propanoate, 19 
 
 
 
Following general cross-coupling Method A using XPhos (24 mg, 0.05 mmol) 
and 4-iodoanisole (303 mg, 1.3 mmol) gave, after purification by silica gel 
column (3% EtOAc in toluene) the title compound (216 mg, 78%) as a yellow 
oil. 
Following general cross-coupling Method B using XPhos (2.4 mg, 0.005 
mmol) and 4-iodoanisole (303 mg, 1.3 mmol) gave, after purification by silica 
gel column (3% EtOAc in toluene) the title compound (231 mg, 68%) as a 
yellow oil. 
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Rf 0.47 (15% EtOAc in toluene); [α]D20 +50.0 (c 1.8, CHCl3) lit. value [α]D20 
+50.0 (c 1.8, CHCl3);18 δH (400 MHz; CDCl3) 1.42 (9H, s, (CH3)3), 3.02 (2H, dd, J 
14.0, 6.0, CH2), 3.71 (3H, s, OCH3), 3.77 (3H, s, ArOCH3), 4.54 (1H, dd, J 14.0, 
6.0, CH), 5.04 (1H, d, J 8.0, NH), 6.83 (2H, d, J 8.5, ArH), 7.04 (2H, d, J 8.5, 
ArH); δC (101 MHz; CDCl3) 28.3, 37.5, 52.2, 54.5, 55.2, 76.7, 77.0, 77.3, 114.0, 
127.9, 130.3, 158.7, 172.4. Spectroscopic data is consistent with that 
previously reported.18  
 
4.2.12 (S)-methyl 2-(tert-butoxycarbonylamino)-3-(thiophen-2-yl)- 
propanoate, 20 
 
 
 
Following a variation of general cross-coupling Method A, (after zinc 
insertion the zinc was allowed to settle and the liquid removed into a 
separate flame dried, nitrogen purged side arm round bottom flask) using 
XPhos (24 mg, 0.05 mmol) and 2-iodothiophene (145 μL, 1.3 mmol) at 50 oC 
gave, after purification by silica gel column (7% EtOAc in toluene) the title 
compound (140 mg, 49%) as a yellow oil. 
Following a variation of general cross-coupling Method A, (after zinc 
insertion the zinc was allowed to settle and the liquid removed into a 
separate flame dried, nitrogen purged side arm round bottom flask) using 
XPhos (24 mg, 0.05 mmol) and 2-bromothiophene (125 μL, 1.3 mmol) at 50 oC 
gave, after purification by silica gel column (7% EtOAc in toluene) the title 
compound (126 mg, 44%) as a yellow oil. 
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Following a variation of general cross-coupling Method A, (after zinc 
insertion the zinc was allowed to settle and the liquid removed into a 
separate flame dried, nitrogen purged side arm round bottom flask) using 
QPhos (35 mg, 0.05 mmol) and 2-bromothiophene (125 μL, 1.3 mmol) at 50 
oC gave, after purification by silica gel column (7% EtOAc in toluene) the title 
compound (71 mg, 25%) as a yellow oil. 
 
Following a variation of general cross-coupling Method B, (after zinc 
insertion the zinc was allowed to settle and the liquid removed into a 
separate flame dried, nitrogen purged side arm round bottom flask) using 
XPhos (2.4 mg, 0.005 mmol) 2-iodothiophene (145 μL, 1.3 mmol) at 50 oC 
gave, after purification by silica gel column (7% EtOAc in toluene) the title 
compound (86 mg, 30%) as a yellow oil. 
Following a variation of general cross-coupling Method B, (after zinc 
insertion the zinc was allowed to settle and the liquid removed into a 
separate flame dried, nitrogen purged side arm round bottom flask) using 
XPhos (2.4 mg, 0.005 mmol) 2-bromothiophene (125 μL, 1.3 mmol) at 50 oC 
gave, after purification by silica gel column (7% EtOAc in toluene) the title 
compound (74 mg, 26%) as a yellow oil. 
[[α]D20 +61 (c 1.0 CHCl3); νmax(film)/cm-1 3375, 2974, 1740, 1715, 1506, 1436, 
1391, 1366, 1247, 1215, 1166, 1060, 1018; δH (400 MHz, CDCl3) 1.46 (9H, s, 
C(CH3)3), 3.31-3.43 (2H, m, CH2), 3.77 (3H, s, OCH3), 4.67-4.57 (1H, m, CH), 
5.18 (1H, d, J 7.5 NH), 6.82 (1H, d, J 3.0, ArH), 6.95 (1H, dd, J 5.0, 3.5, ArH), 
7.19 (1H, d, J 5.0, ArH); δC (101 MHz, CDCl3) 28.4, 32.4, 52.4, 54.2, 80.0, 124.7, 
126.7, 127.0, 137.3, 155.0, 171.7; m/z (ES) Found: MH+ 286.1119. C13H20NO4S 
requires MH+ 286.1113. 
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4.2.13 (S)-methyl 2-{[(tert-butoxy)carbonyl]amino}-3-(thiophen-3-yl)-
propanoate, 21 
 
 
 
Following a variation of general cross-coupling Method A, (after zinc 
insertion the zinc was allowed to settle and the liquid removed into a 
separate flame dried, nitrogen purged side arm round bottom flask) using 
XPhos (24 mg, 0.05 mmol) and 3-iodothiophene (135 μL, 1.3 mmol) at 50 oC 
gave, after purification by silica gel column (7% EtOAc in toluene) the title 
compound (185 mg, 65%) as a yellow oil. 
Following a variation of general cross-coupling Method A, (after zinc 
insertion the zinc was allowed to settle and the liquid removed into a 
separate flame dried, nitrogen purged side arm round bottom flask) using 
XPhos (24 mg, 0.05 mmol) and 3-bromothiophene (122 μL, 1.3 mmol) at 50 oC 
gave, after purification by silica gel column (7% EtOAc in toluene) the title 
compound (171 mg, 60%) as a yellow oil. 
Following a variation of general cross-coupling Method B, (after zinc 
insertion the zinc was allowed to settle and the liquid removed into a 
separate flame dried, nitrogen purged side arm round bottom flask) using 
XPhos (2.4 mg, 0.005 mmol) 3-iodothiophene (135 μL, 1.3 mmol) at 50 oC 
gave, after purification by silica gel column (7% EtOAc in toluene) the title 
compound (157 mg, 50%) as a yellow oil. 
Following a variation of general cross-coupling Method B, (after zinc 
insertion the zinc was allowed to settle and the liquid removed into a 
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separate flame dried, nitrogen purged side arm round bottom flask) using 
XPhos (2.4 mg, 0.005 mmol) 3-bromothiophene (122 μL, 1.3 mmol) at 50 oC 
gave, after purification by silica gel column (7% EtOAc in toluene) the title 
compound (143 mg, 50%) as a yellow oil. 
[α]D20 +48 (c 1.0 CHCl3). νmax(film)/cm-1 3368, 3095, 2974, 2357, 1743, 1711, 
1503, 1438, 1392, 1366, 1282, 1246, 1166, 1059, 1020; δH (400 MHz, CDCl3) 1.45 
(9H, s, C(CH3)3), 3.12-3.22 (2H, m, CH2), 3.73 (3H, s, OCH3), 4.58 (1H, dd, J 
14.0, 6.0, CH), 5.1 (1H, d, J 8.0 NH), 6.88 (1H, d, J 5.0, ArH), 7.01 (1H, s, ArH), 
7.27 (1H, dd, J 5.0, 3.0, ArH);  δC (101 MHz, CDCl3) 28.1, 32.6, 52.3, 55.0, 80.2, 
122.7, 125.8, 128.2, 136.3, 155.1, 172.4; m/z (ES) Found: MH+ 286.1118. 
C13H20NO4S requires MH+ 286.1113. 
 
4.2.14 (S)-methyl 2-(tert-butoxycarbonylamino)-3-(furan-3-yl)- propanoate, 
22 
 
 
 
Following general cross-coupling Method A using XPhos (24 mg, 0.05 mmol) 
and 3-bromofuran (117 μL, 1.3 mmol) at 50 oC gave, after purification by 
silica gel column (3% EtOAc in toluene) the title compound (78 mg, 29%) as a 
yellow oil. 
Following general cross-coupling Method A using QPhos (35 mg, 0.05 
mmol) and 3-bromofuran (117 μL, 1.3 mmol) at 50 oC gave, after purification 
by silica gel column (3% EtOAc in toluene) the title compound (59 mg, 22%) 
as a yellow oil. 
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 [α]D23 +11 (c 1.0 CHCl3), νmax (film)/cm-1 3359, 3108, 2975, 1740, 1721, 1504, 
1437, 1395, 1363, 1238, 1211, 1166, 1059, 1021; δH (400 MHz, CDCl3) 1.45 (9H, 
s, C(CH3)3), 3.24-3.10 (2H, m, CH2), 3.76 (s, 3H, OCH3), 4.61 (1H, dd, J  14.0, 
5.5, CH), 5.06 (d, J  8.0, NH), 6.87 (1H, d, J 5.0, ArH), 7.02 (1H, d, J 2.5, ArH), 
7.27 (1H, dd, J 5.0, 2.5, ArH); δC (101 MHz, CDCl3) 28.2, 32.7, 52.1, 53.7, 80.3, 
122.9, 126.1, 128.2, 136.0, 155.1, 172.3; Found: MH+ 270.1191. C13H20NO4S 
requires MH+ 270.1187. 
 
4.2.15 Methyl (2S)-2-{[(tert-butoxy)carbonyl]amino}-3-(pyridin-2-yl)-
propanoate, 23 
 
 
 
Following general cross-coupling Method A using XPhos (24 mg, 0.05 mmol) 
and 2-chloropyridine (123 μL, 1.3 mmol) at 50 oC gave, after purification by 
silica gel column (3% EtOAc in toluene) the title compound (31 mg, 11%) as a 
yellow oil. 
Following general cross-coupling Method A using QPhos (35 mg, 0.05 
mmol) and 2-chloropyridine (123 μL, 1.3 mmol) at 50 oC gave, after 
purification by silica gel column (3% EtOAc in toluene) the title compound 
(36 mg, 13%) as a yellow oil. 
 
[α]D22 +23 (c 1.0 CHCl3), lit. value [α]D23 +21.5 (c 1.0, CHCl3);93 δH (400 MHz, 
CDCl3) 1.44 (9H, s, C(CH3)3), 3.28 (1H, dd, J 4.5, 14.5, CH), 3.36 (1H, dd, J 6.0, 
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14.5, CH), 3.71 (3H, s, OCH3), 4.66-4.75 (1H, m), 5.90 (1H, d, J 8.0, NH), 7.14-
7.21 (2H, m, ArH), 7.63 (1H, dt, J 1.5, 4.0, ArH), 8.55 (1H, br s, ArH), δC (101 
MHz, CDCl3) 28.3, 39.2, 52.3, 53.0, 79.8, 121.9, 123.9, 136.9, 148.8, 155.5, 157.1, 
172.4. Proton and carbon Spectroscopic data is consistent with that 
previously reported.93 
 
4.2.16 4-iodo-1H-pyrazole, 24 
 
 
 
To a mixture of pyrazole (25.53 g, 375 mmol) and iodine (47.6 g, 187.5 mmol) 
in H2O (224 mL) was added 30 wt% H2O2 (26 mL). The reaction mixture was 
stirred for 48 h at room temperature, on which cold saturated sodium 
thiosulfate was added until the reaction mixture was colourless. The mixture 
was then vacuum filtered to give a brown solid, which was recystallised 
using hot H2O to give the desired product as colourless needles (38.1 g, 52% 
yield); m.p. 108-109 °C, lit. m.p. 105-107 °C;94 246 δH (400 MHz, CDCl3) 7.67 
(2H, s, ArH), 10.29 (1H, s, NH); δC (101 MHz, CDCl3) 56.6, 138.7. 
Spectroscopic data is consistent with that previously reported.94 
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4.2.17 tert-Butyl 4-iodopyrazol-1-yl carboxylate, 25  
 
 
 
A solution of Boc2O (5.6 g, 26 mmol) in MeCN (40 mL) was added to a 
mixture of 4-iodopyrazole (4.66 g, 24 mmol) and 4-DMAP (0.3 g, 2.4 mmol) 
and left to stir overnight at room temperature. The reaction mixture was then 
concentrated under reduced pressure and dissolved in EtOAc. The reaction 
mixture was then washed with 1M HCl, followed by water and brine. The 
organic layer was dried over MgSO4, and the solvent removed under 
reduced pressure to give the product as an amorphous white solid (4.66 g, 
68% yield); m.p. 66-70 °C; δH (400 MHz, CDCl3) 1.65 (9H, s, C(CH3)3), 7.70 
(1H, s, ArH), 8.15 (1H, s, ArH); δC (101 MHz, CDCl3) 27.8, 61.2, 86.1, 134.9, 
148.3, 171.3 . 
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4.3 Chapter 3 Experimental 
 
Phthalimide protection of amino acids Method A: 
 
The amino acid (100 mmol) and phthalic anhydride (14.8 g, 100 mmol) were 
heated at 160 °C for 2 h in a 250 mL round-bottom flask. After cooling to rt, 
the solid mixture was dissolved in the minimum the amount of boiling 
methanol. The filtrate was diluted with cold water until a white solid slowly 
appeared. The precipitate was collected and further washed with cold water. 
 
8-Aminoquinoline amide formation Method B: 
 
Starting material (20 mmol), thionylchloride (4.5 mL, 60 mmol) and 4 drops 
of DMF were heated in toluene at 80 °C for 3 h under nitrogen. The toluene 
and excess thionylchloride were removed by vacuum distillation and the 
remaining acid chloride was dissolved in anhydrous CH2Cl2 (10 mL). 
8-Aminoquinoline (2.88 g, 20 mmol) and EtiPr2N (4 mL, 26 mmol) were 
dissolved in anhydrous CH2Cl2 (30 mL) and cooled to 0 oC. The acid chloride 
solution was added dropwise by cannula and the resulting reaction mixture 
was stirred overnight at rt. The reaction was then diluted with water (50 mL) 
and extracted with CH2Cl2 (2 x 50 mL). The combined organic layers were 
washed with 1 M HCl (50 mL), saturated aqueous NaHCO3 (50 mL) and 
brine (50 mL), dried over MgSO4 and the solvent removed under reduced 
pressure to give the crude product. 
Aromatic iodination Method C: 
A solution of quinoline amide starting material (3 mmol) PhI(OAc)2 (966 mg, 
3.0 mmol) and iodine (756 mg, 3 mmol) in CH2Cl2 (24 mL) was stirred at 
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room temperature overnight. The reaction mixture was washed with 
Na2S2O3, dried over MgSO4 and the solvent removed under reduced pressure 
to give the crude product. 
 
4.3.1 (2S)-2-(1,3-dioxo-2,3-dihydro-1H-isoindol-2-yl)propanoic acid, 67 
 
 
Following phthalimide protection of amino acids Method A using L-alanine 
(8.9 g, 100 mmol) gave the title compound at a white amorphous solid (16.4 
g, 75%); m.p. 143-144 °C, lit. value 144-146 °C;95 [α]D20 -26.8 (c 2.6, EtOH), 
lit.value [α]D20 -24.2 (c 2.6 , EtOH);95 δH (400 MHz; CDCl3) 1.48 (3H, d, J 7.5, 
CH3), 4.98 (1H, q, 7.5, CH), 7.72 (2H, dd, J 5.5, 3.0, ArH), 7.84 (2H, dd, J 5.5, 
3.0, ArH); δC (101 MHz; CDCl3) 14.0, 47.2, 122.8, 131.8, 134.2, 167.3, 175.7. 
Spectroscopic data is consistent with that previously reported.95 
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4.3.2 (S)-2-(1,3-Dioxo-1,3-dihydroisoindol-2-yl)-N-quinolin-8-yl-propion-
amide, 50  
 
 
Following 8-aminoquinoline amide formation Method B using (2S)-2-(1,3-
dioxo-2,3-dihydro-1H-isoindol-2-yl)propanoic acid 67 (4.4 g, 20 mmol) after 
purification by silica gel column chromatography (10% EtOAc in toluene) 
gave the product (5.6 g, 81%) as an amorphous cream solid; m.p. 190-192 °C, 
lit value 190-193 °C;66 [α]D22 + 1.2 (c 1.7, CHCl3), lit. value [α]D25 +1.05 (c 1.7, 
CHCl3);66  δH (400 MHz; CDCl3) 2.00 (3H, d, J 7.5, CH3), 5.30 (1H, q, J 7.5, CH), 
7.46 (1H, dd, J 8.5, 4.5, ArH), 7.54 (1H, s, ArH), 7.55 (1H, d, J 3.0, ArH), 7.77 
(2H, dd, J 5.5, 3.0 ArH), 7.92 (2H, dd, J 5.5, 3.0 ArH), 8.20 (1H, dd, J 8.5, 1.5 
ArH), 8.72 (1H,  dd, J 4.5, 1.5 ArH), 8.75 (1H, dd, J 5.5, 3.0 ArH), 10.37 (1H, s, 
NH); δC (101 MHz; CDCl3) 15.5 , 50.1, 117.0, 121.6, 122.0, 123.6, 127.4 , 127.9, 
132.0, 133.8, 134.2, 136.6, 138.4, 148.1, 167.3, 167.9. Spectroscopic data is 
consistent with that previously reported.66 
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4.3.3 (R)-2-(1,3-Dioxo-1,3-dihydroisoindol-2-yl)-3-iodo-N-quinolin-8-yl-
propionamide, 53 
 
A solution of (S)-2-(1,3-dioxo-1,3-dihydroisoindol-2-yl)-N-quinolin-8-yl-
propionamide 50 (3.45 g, 10 mmol), Pd(OAc)2 (225 mg, 1 mmol), I2 (3.8 g, 15 
mmol) and Ag2CO3 (2.76 g, 10 mmol) in CH2Cl2 (10 mL) was stirred overhead 
at room temperature for 50 h. The reaction mixture was filtered, extracted 
with CH2Cl2 (2 x 50 mL), washed with 10% Na2S2O3 (50 mL) and dried over 
MgSO4. The solvent was removed under reduced pressure and the crude 
product purified using silica gel column chromatography (5% EtOAc in 
toluene) to give the product (3.12 g, 66%) (>99% ee.) as a white solid (m.p. 
112-114 °C); [α]D20 +33 (c 1.0, CHCl3); νmax (film)/cm-1 3325, 2935, 1779, 1721, 
1688, 1532; δH (400 MHz; CDCl3) 4.18 (1H, dd, J 10.5, 5.0, CHHI), 4.30 (1H, dd, 
J 11.5, 10.5 CHHI),  5.38 (1H, dd, J 11.5, 5.0, CH), 7.43 (1H, dd, J 8.5, 4.0, ArH), 
7.54 (1H, d, J 2.0, ArH), 7.55 (1H, s, ArH), 7.83 (2H, dd, J 5.5, 3.0, ArH ), 7.98 
(2H, dd, J 5.5, 3.0, ArH), 8.16 (1H, dd, J 8.5, 1.5, ArH), 8.64 (1H, dd, J 4.0, 1.5, 
ArH), 8.69 (1H, dd, J 5.5, 3.5, ArH),  10.38 (1H, s, NH); δC (101 MHz; CDCl3) 
0.8, 57.2, 117.0, 121.7, 122.4, 124.0, 127.9, 131.7, 133.5, 134.6, 136.4, 138.4, 140.4, 
148.4, 164.0, 167.5; m/z (ES) Found: MH+, 472.0169. C20H15N3O3I requires MH+ 
472.0158; CSP-HPLC: Lux 3u cellulose-2 (20% iPrOH in hexane, 0.7 mL/min) 
(S)-53 33.02 min, (R)-53 45.22 min. 
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4.3.4 (2S)-2-(1,3-dioxo-2,3-dihydro-1H-isoindol-2-yl)-3-phenylpropanoic 
acid, 68 
  
Following phthalimide protection of amino acids Method A using L-
phenylalanine (16.4 g, 100 mmol) gave the title compound at a white 
amorphous solid (20.9 g, 72%);95 m.p. 181-183 °C, lit. value 182-183 °C;95 [α]D20 
-209 (c 4.2, EtOH), lit.value [α]D20 -212 (c 4.2 , EtOH); δH (400 MHz; CDCl3) 
3.42-3.6 (2H, m, CH2), 5.12-5.19 (1H, dd, J 11.5, 5.0, CH), 7.08-7.18 (5H, m, 
ArH), 7.71-7.78 (4H, m, ArH); δC (101 MHz; CDCl3) 34.1, 53.2, 122.8, 126.4, 
128.1, 128.4, 131.1, 137.8, 134.2, 168.3, 171.5. Spectroscopic data is consistent 
with that previously reported.95 
 
4.3.5 (2S)-2-(1,3-dioxo-2,3-dihydro-1H-isoindol-2-yl)-4-methylpentanoic 
acid, 69 
 
Following phthalimide protection of amino acids Method A using L-leucine 
(13.1 g, 100 mmol) gave the title compound at a white amorphous solid (22.4 
g, 86%); m.p. 123-124 °C, lit. value 121-122 °C;95 [α]D21 -26 (c 1.0, EtOH), lit. 
value [α]D 20 -25.5 (c 1.0, EtOH);95 δH (400 MHz; CDCl3) 0.96 (3H, d, J 6.5, 
CH(CH3)2), 1.09 (3H, d, J 6.5, CH(CH3)2), 1.42-1.54 (1H, m, CH(CH3)2), 1.86 
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(1H, ddd, J 14.0, 10.0, 4.0, CH2), 2.35 (1H, ddd, J 14.0, 11.5, 4.0, CH2), 5.36 (1H, 
dd, J 11.5, 4.0, CH(CH2)), 7.76 (2H, dd, J 5.5, 3.0, ArH), 7.88 (2H, dd, J 5.5, 3.0, 
ArH);  δC (101 MHz; CDCl3) 19.8, 23.1, 25.0, 37.0, 50.4, 123.0, 131.6 ,134.3, 
167.9, 175.7. Spectroscopic data is consistent with that previously reported.95 
 
4.3.6 (2S)-2-(1,3-dioxo-2,3-dihydro-1H-isoindol-2-yl)-3-methylpentanoic 
acid, 70 
 
Following phthalimide protection of amino acids Method A using L-
isoleucine (13.1 g, 100 mmol) gave the title compound at a white amorphous 
solid (21.9 g, 86%); m.p. 123-124 °C, lit. value 121-123 °C;96 [α]D21 -59 (c 1.0, 
MeOH), lit. value [α]D 20 -56 (c 1.0, MeOH);96 δH (400 MHz; CDCl3) 0.89 (3H, t, 
J 7.5, CH2CH3), 0.99-1.1 (1H, m CH2), 1.14 (3H, d, J 6.5, CHCH3), 1.49-1.59 (1H, 
m, CH2), 2.41-2.52 (1H, m, CH), 4.63 (1H, d, J 8.0, CH), 7.85 (2H, dd, J 5.5, 3.0, 
ArH), 7.91 (2H, dd, J 5.5, 3.0, ArH); δC (101 MHz; CDCl3) 9.9, 16.0, 25.6, 34.3, 
56.7, 123.0, 131.5, 134.3, 167.9, 170.7. Spectroscopic data is consistent with 
that previously reported.96 
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4.3.7 (2S)-2-(1,3-dioxo-2,3-dihydro-1H-isoindol-2-yl)-3-phenyl-N-(quinolin-
8-yl)-propanamide, 71 
 
 
Following 8-aminoquinoline amide formation Method B using (2S)-2-(1,3-
dioxo-2,3-dihydro-1H-isoindol-2-yl)-3-phenylpropanoic acid 68 (5.9 g, 20 
mmol) after purification by silica gel column chromatography (10% EtOAc in 
toluene) gave the product (7.1g, 75%) as an amorphous cream solid; m.p. 
119-121 °C, lit value 120-122 °C;66 [α]D22 + 64 (c 0.8, CHCl3), lit. value [α]D25 
+61.1 (c 0.8, CHCl3);66  δH (400 MHz; CDCl3) 3.78-3.89 (2H, m, CH2), 5.48 (1H, 
dd, J 10.0, 7.0 CH), 7.12-7.21 (5H, m, ArH), 7.43 (1H, dd, J 8.5, 4.5, ArH), 7.54 
(1H, s, ArH), 7.55 (1H, d, J 3.0, ArH), 7.73 (2H, dd, J 5.5, 3.0 ArH), 7.85 (2H, 
dd, J 5.5, 3.0 ArH), 8.15 (1H, dd, J 8.5, 1.5 ArH), 8.64 (1H,  dd, J 4.5, 1.5 ArH), 
8.76 (1H, dd, J 6.5, 3.0 ArH), 10.37 (1H, s, NH); δC (101 MHz; CDCl3) 34.8, 
56.2, 116.9, 121.6, 122.0, 123.6, 127.0, 127.3, 127.9, 128.7, 129.0, 131.6, 133.8, 
134.2, 136.3, 136.7, 138.0, 148.3, 167.9, 166.4. Spectroscopic data is consistent 
with that previously reported.66 
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4.3.8 (2S)-2-(1,3-dioxo-2,3-dihydro-1H-isoindol-2-yl)-4-methyl-N-(quinolin-
8-yl)-pentanamide, 72 
 
 
Following 8-aminoquinoline amide formation Method B using (2S)-2-(1,3-
dioxo-2,3-dihydro-1H-isoindol-2-yl)-4-methylpentanoic acid 69 (5.2 g, 20 
mmol) after purification by silica gel column chromatography (10% EtOAc in 
toluene) gave the product (6.1 g, 79%) as an amorphous cream solid; m.p. 
119-121 °C, lit value 190-193 °C;66 [α]D22 + 2.0 (c 1.8, CHCl3), lit. value [α]D25 
+1.5 (c 1.8, CHCl3);66  δH (400 MHz; CDCl3) 1.05 (3H, d, J 6.5, CH(CH3)2), 1.08 
(3H, d, J 6.5, CH(CH3)2), 1.62-1.69 (1H, m, CH(CH3)2), 2.13 (1H, ddd, J 14.5, 
9.5, 5.0, CH2), 2.68 (1H, ddd, J 14.5, 11.5, 4.0, CH2), 5.36 (1H, dd, J 11.5, 5.0, 
CH(CH2)), 7.44 (1H, dd, J 8.5, 4.5, ArH), 7.52 (1H, s, ArH), 7.53 (1H, d, J 17.5, 
ArH), 7.78 (2H, dd, J 5.5, 3.0 ArH), 7.93 (2H, dd, J 5.5, 3.0 ArH), 8.20 (1H, dd, 
J 8.5, 1.5 ArH), 8.72 (1H,  dd, J 4.5, 1.5 ArH), 8.70-8.75 (1H, m, ArH), 10.37 
(1H, s, NH); δC (101 MHz; CDCl3) 21.3, 23.3, 25.6, 37.4, 53.6, 116.7, 121.6, 
121.9, 123.6, 127.3, 127.9, 131.9, 133.9, 134.2, 136.3, 138.5, 148.5, 167.4, 168.1. 
Spectroscopic data is consistent with that previously reported.66 
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4.3.9 (2S)-2-(1,3-dioxo-2,3-dihydro-1H-isoindol-2-yl)-3-methyl-N-(quinolin-
8-yl)pentanamide, 73 
 
 
 
Following 8-aminoquinoline amide formation Method B using (2S)-2-(1,3-
dioxo-2,3-dihydro-1H-isoindol-2-yl)-3-methylpentanoic acid 70 (5.2 g, 20 
mmol) after purification by silica gel column chromatography (10% EtOAc in 
toluene) gave the product (5.8 g, 76%) as an amorphous cream solid m.p; 
143-145 °C, lit value 140-142 °C;66 [α]D22 -33 (c 1.7, CHCl3), lit. value [α]D25 -
30.6 (c 1.3, CHCl3);66  δH (400 MHz; CDCl3) 0.95 (3H, t, J 7.5, CH2CH3), 1.12-
1.23 (1H, m CH2), 1.20 (3H, d, J 6.5, CHCH3), 1.51-1.67 (1H, m, CH2), 3.06-3.14 
(1H, m, CH), 4.80 (1H, d, J 11.0, CH), 7.47 (1H, dd, J 8.0, 4.5, ArH), 7.52 (1H, s, 
ArH), 7.53 (1H, s, ArH), 7.74 (2H, dd, J 5.5, 3.0 ArH), 7.90 (2H, dd, J 5.5, 3.0 
ArH), 8.15 (1H, dd, J 8.0, 1.5 ArH), 8.72 (1H,  dd, J 4.5, 1.5 ArH), 8.78 (1H, dd, 
J 4.5, 4.5 ArH), 10.64 (1H, s, NH); δC (101 MHz; CDCl3) 10.4, 16.4, 25.7, 32.8, 
62.1, 117.0, 121.6, 122.0, 123.7, 127.2, 127.9, 131.6, 134.2, 134.3, 136.2, 138.72, 
148.55, 167.0, 168.3. Spectroscopic data is consistent with that previously 
reported.66 
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4.3.10 (2S)-2-(1,3-dioxo-2,3-dihydro-1H-isoindol-2-yl)-N-(5-iodoquinolin-8-
yl)-3-phenylpropanamide, 74 
 
 
Aromatic iodination Method C using (2S)-2-(1,3-dioxo-2,3-dihydro-1H-
isoindol-2-yl)-3-phenyl-N-(quinolin-8-yl)-propanamide 71 (1.3 g, 3 mmol) 
after purification by silica gel column chromatography (5% EtOAc in 
toluene) gave the product (1.2 g, 74%) as an amorphous yellow solid m.p. 
163-165 °C; [α]D22 - 60 (c 1.0, CHCl3); νmax (film)/cm-1 3336, 3065, 2918, 1778, 
1715, 1522, 1469, 1388, 1528; δH (400 MHz; CDCl3) 3.76-3.85 (2H, m, CH2), 5.46 
(1H, dd, J 10.0, 6.5 CH), 7.12-7.32 (5H, m, ArH), 7.50 (1H, dd, J 8.5, 4.5, ArH), 
7.74 (2H, dd, J 5.5, 3.0 ArH), 7.85 (2H, dd, J 5.5, 3.0 ArH), 8.01 (1H, d, J 8.5 
ArH), 8.35 (1H,  dd, J 8.5, 1.5 ArH), 8.53 (1H, d, J 8.5 ArH), 8.60 (1H, dd, J 4.5. 
1.5), 10.33 (1H, s, NH); δC (101 MHz; CDCl3) 34.8, 56.3, 90.0, 118.2, 123.2, 
123.6, 127.0, 128.7, 129.0, 129.6, 131.6, 134.2, 134.8, 136.6, 138.2, 139.0, 140.7, 
148.9, 166.5, 167.9; m/z (ES) Found: MH+, 548.0446. C26H19N3O3I requires MH+ 
548.0471. 
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4.3.11 (2S)-2-(1,3-dioxo-2,3-dihydro-1H-isoindol-2-yl)-N-(5-iodoquinolin-8-
yl)-4-methylpentanamide, 75 
 
 
Aromatic iodination Method C using (2S)-2-(1,3-dioxo-2,3-dihydro-1H-
isoindol-2-yl)-4-methyl-N-(quinolin-8-yl)-pentanamide 72 (1.2 g, 3 mmol) 
after purification by silica gel column chromatography (5% EtOAc in 
toluene) gave the product (1.2 g, 78%) as an amorphous cream solid; m.p. 
136-138 °C; [α]D22 -13 (c 1.0, CHCl3); νmax (film)/cm-1 3339, 2959, 2931, 1778, 
1709, 1522, 1472, 1382, 1316; δH (400 MHz; CDCl3) 1.05 (3H, d, J 6.5, 
CH(CH3)2), 1.08 (3H, d, J 6.5, CH(CH3)2), 1.60-1.70 (1H, m, CH(CH3)2), 2.12 
(1H, ddd, J 14.0, 9.5, 5.0, CH2), 2.65 (1H, ddd, J 14.0, 11.5, 4.0, CH2), 5.23 (1H, 
dd, J 11.5, 5.0, CH(CH2)), 7.53 (1H, dd, J 8.5, 4.0, ArH), 7.79 (2H, dd, J 5.5, 3.0 
ArH), 7.93 (2H, dd, J 5.5, 3.0 ArH), 8.07 (1H, d, J 8.5 ArH), 8.37 (1H,  dd, J 8.5, 
1.5 ArH), 8.51 (1H, d, J 8.5 ArH), 8.70 (1H, dd, J 4.0. 1.5), 10.35 (1H, s, NH); δC 
(101 MHz; CDCl3) 21.3, 23.2, 25.6, 37.4, 53.7, 89.8, 118.1, 123.2, 123.7, 129.6, 
131.8, 134.3, 134.9, 138.2, 139.1, 140.7, 149.0, 167.5, 168.1; m/z (ES) Found: 
MH+, 514.0651. C23H21N3O3I requires MH+ 514.0628. 
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4.3.12 (2S)-2-(1,3-dioxo-2,3-dihydro-1H-isoindol-2-yl)-N-(5-iodoquinolin-8-
yl)-3-methylpentanamide, 76 
 
 
Aromatic iodination Method C using (2S)-2-(1,3-dioxo-2,3-dihydro-1H-
isoindol-2-yl)-3-methyl-N-(quinolin-8-yl)pentanamide 73 (1.2 g, 3 mmol) 
after purification by silica gel column chromatography (5% EtOAc in 
toluene) gave the product (1.1 g, 76%) as an amorphous cream solid; m.p. 
134-136 °C; [α]D22 - 48 (c 1.0, CHCl3); νmax (film)/cm-1 3339, 2972, 2927, 1771, 
1715, 1525, 1472, 1378, 1067; δH (400 MHz; CDCl3) 0.95 (3H, t, J 7.5, CH2CH3), 
1.16-1.21 (1H, m CH2), 1.19 (3H, d, J 6.5, CHCH3), 1.51-1.59 (1H, m, CH2), 
3.02-3.12 (1H, m, CH), 4.79 (1H, d, J 11.0, CH), 7.56 (1H, dd, J 8.5, 4.0, ArH), 
7.76 (2H, dd, J 5.5, 3.0 ArH), 7.91 (2H, dd, J 5.5, 3.0 ArH), 8.07 (1H, d, J 8.5 
ArH), 8.37 (1H,  dd, J 8.5, 1.5 ArH), 8.57 (1H, d, J 8.5 ArH), 8.87 (1H, dd, J 4.0. 
1.5), 10.66 (1H, s, NH); δC (101 MHz; CDCl3) 10.3, 16.3, 25.6, 32.8, 62.1, 90.0, 
118.4, 123.2, 123.7, 129.6, 131.6, 134.3, 135.3, 138.1, 139.2, 140.6, 149.1, 167.4, 
168.2; m/z (ES) Found: MH+, 514.0606. C23H21N3O3I requires MH+ 514.0628. 
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4.3.13 (2S)-2-(acetyloxy)propanoic acid, 77 
 
 
To a solution of L-lactic acid (90 w% in H2O, 4.2 mL, 56 mmol) in pyridine 
(5.6 mL, 69 mmol) was added acetic acid (5.3 mL, 56 mmol) at 0 oC, followed 
by stirring at rt for 24 h. The reaction mixture was then poured onto ice 
water (25 mL), stirred for a further hour before being extracted in EtOAc (3 x 
30 mL), washed with HCl (1 M, 3 x 30 mL), dried over MgSO4 and the 
solvent removed under reduced pressure. The crude product was purified 
via vacuum distillation (11 mmHg, 115 oC) to give the product as a colourless 
oil (4.89 g, 66%); [α]D20 -50.9 (c 2.28, CHCl3), lit. value88 [α]D21 -47.5 (c 2.28, 
CHCl3); δH (400 MHz; CDCl3) 1.51 (3H, d, J 7.0  CH3), 2.11 (3H, s, CH3), 5.08 
(1H, q, J 7.0, CH), 10.75 (1H, s, COOH); δC (101 MHz; CDCl3) 16.7, 20.51, 68.2, 
170.8, 176.3. Spectroscopic data is consistent with that previously reported.88    
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4.3.14 (1S)-1-[(quinolin-8-yl)carbamoyl]ethyl acetate, 78 
 
Following 8-aminoquinoline amide formation Method B using (2S)-2-
(acetyloxy)propanoic acid 77 (2.6 g, 20 mmol) after purification by silica gel 
column chromatography (5% EtOAc in toluene) gave the product (4.16 g, 
81%) as a cream amorphous solid; m.p 39-41 oC; [α]D20 -95 (c 1.0, CHCl3); νmax 
(film)/cm-1 3344, 2927, 1745 (C=O), 1686 (C=O), 1528; δH (400 MHz; CDCl3) 
1.66 (3H, d, J 7.0, CH3), 2.32 (3H, s, CH3), 5.48 (1H, q, J 7.0, CH), 7.45 (1H, dd, 
J 8.5, 4.0, ArH), 7.52 (1H, s, ArH), 7.53 (1H, d, J  2.0, ArH), 8.15 (1H, dd, J 8.5, 
1.5, ArH), 8.75 (1H, dd, J 3.5, 5.5, ArH), 8.81 (1H, dd, J 4.0, 1.5, ArH), 10.56 
(1H, s, NH); δC (101 MHz; CDCl3) 18.0, 21.1, 71.1, 116.6, 121.7, 122.1, 127.3, 
127.9, 133.7, 136.4, 138.6, 148.5, 168.9, 169.0;  m/z (ES) Found: MH+, 259.1090. 
C14H15N2O3 requires MH+ 259.1083. 
 
4.3.15 (2S)-2-hydroxy-N-(quinolin-8-yl)propanamide, 82 
 
K2CO3 (1g) was added to a solution of (1S)-1-[(quinolin-8-yl)carbamoyl]ethyl 
acetate 78 (258 mg, 1 mmol) in MeOH (8 mL) at 0 oC. The resulting reaction 
mixture was then stirred at rt for 4 h. The reaction mixture was extracted in 
EtOAc (2 x 50 ml), washed with brine (50 ml), dried over MgSO4 and the 
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solvent removed under reduced pressure. The crude product was then 
purified using silica gel column chromatography (40% EtOAc in toluene) to 
give the product as a yellow oil (215 mg, 99%); [α]D20 -11 (c 1.0, CHCl3); νmax 
(film)/cm-1 3389, 3324, 1662 (C=O), 1528; δH (400 MHz; CDCl3) 1.64 (3H, d, J  
7.0, CH3), 4.0 (1H, brs, OH), 4.57 (1H, q, J 7.0, CH), 7.40 (1H, dd, J 8.5, 4.0, 
ArH), 7.46 (1H, s, ArH), 7.47 (1H, d, J 4.5, ArH), 8.11 (1H, dd, J 8.5, 1.5, ArH), 
8.73 (1H, dd, J 5.0, 4.5, ArH), 8.79 (1H, dd, J 4.0, 1.5, ArH), 10.79 (1H, s, NH). 
δC (101 MHz; CDCl3) 21.3, 69.3, 116.8, 121.6, 122.1, 127.2, 128.0, 133.7, 136.3, 
138.7, 148.5, 173.5; m/z (ES) Found: MH+, 217.0932. C12H12N2O2 requires MH+ 
217.0925. 
 
4.3.16 (2S)-2-[(tert-butyldimethylsilyl)oxy]-N-(quinolin-8-yl-propanamide, 
83 
 
To a solution of 2-hydroxy-N-(quinolin-8-yl)propanamide 82 (432 mg, 2 
mmol) and imidazole (348 mg, 5 mmol) in CH2Cl2 (1 mL) at 0 oC was added 
TBDMSCl (362 mg, 2.4 mmol). The reaction was stirred at room temperature 
for 10 hours. The reaction was diluted with CH2Cl2 (5 mL), and H2O (10 mL) 
and further extracted with CH2Cl2 (3 x 5 mL). The combined organic extracts 
were dried over MgSO4 and the solvent removed under reduced pressure. 
The crude product was purified using silica gel column chromatography (5% 
EtOAc in toluene) to give the product as a yellow oil (628 mg, 95%); [α]D20 -74 
(c 1.0, CHCl3); νmax (film)/cm-1 3344, 2927, 1686 (C=O), 1528, 1090; δH (400 
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MHz; CDCl3) 0.22 (6H, s, CH3), 1.10 (9H, s, CH3), 1.57 (3H, d, J 7.0, CH3), 4.47 
(1H, q, J 7.0, CH), 7.46 (1H, dd, J 8.5, 4.0, ArH), 7.54 (1H, s, ArH), 7.56 (1H, d, 
J 4.0, ArH), 8.17 (1H, dd, J 8.5, 1.5, ArH), 8.80 (2H, m, ArH), 11.17 (1H, s, 
NH); δC (101 MHz; CDCl3) -4.5 , 18.1, 25.7, 29.7, 70.7, 116.2, 121.6, 121.7, 127.3, 
128.0, 134.3, 136.1, 139.0, 148.1, 173.1; m/z (ES) Found: MH+, 331.1845. 
C18H26N2O2Si requires MH+ 331.1853. 
 
4.3.17 (1S)-1-[(5-iodoquinolin-8-yl)carbamoyl]ethylacetate, 80 
 
 
 
Aromatic iodination Method C using (1S)-1-[(quinolin-8-yl)carbamoyl]ethyl 
acetate 78 (0.77 g, 3 mmol) after purification by silica gel column 
chromatography (10% EtOAc in toluene) gave the product (0.99 g, 86%) as a 
pale yellow oil; [α]D22 - 63 (c 1.0, CHCl3); νmax (film)/cm-1 3342, 2915, 2847, 
1743, 1687, 1528, 1475, 1226; δH (400 MHz; CDCl3) 1.67 (3H, d, J 7.0, CH3), 2.33 
(3H, s, CH3), 5.48 (1H, q, J 7.0, CH), 7.58 (1H, dd, J 8.5, 4.5, ArH), 8.12 (1H, d, J 
8.0 ArH), 8.42 (1H,  dd, J 8.5, 1.5 ArH), 8.56 (1H, d, J 8.0 ArH), 8.87 (1H, dd, J 
4.5. 1.5), 10.56 (1H, s, NH); δC (101 MHz; CDCl3) 17.9, 21.1, 71.0, 89.1, 118.1, 
121.7, 123.3, 127.9, 133.7, 136.4, 138.2, 148.5, 168.9, 169.0;  m/z (ES) Found: 
MH+, 385.0039. C14H14N2O3I requires MH+ 385.0049. 
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4.3.18 (1R)-2-iodo-1-[(5-iodoquinolin-8-yl)carbamoyl]ethyl acetate, 81 
 
 
A solution of (1S)-1-[(5-iodoquinolin-8-yl)carbamoyl]ethylacetate 80 (384 mg, 
1 mmol), Pd(OAc)2 (22.5 mg, 0.1 mmol), I2 (380 mg, 1.5 mmol) and Ag2CO3 
(276 mg, 1 mmol) in CH2Cl2 (10 mL) was stirred at rt for 1 week. The reaction 
mixture was filtered, extracted with CH2Cl2 (2 x 5 mL), washed with 10% 
Na2S2O3 (5 mL) and dried over MgSO4. The solvent was removed under 
reduced pressure and the crude product purified using silica gel column 
chromatography (10% EtOAc in toluene) to give the product (30 mg, 8%) as a 
pale yellow oil; [α]D20 -14 (c 1.0, CHCl3); νmax (film)/cm-1 3333, 2921, 2853, 1749, 
1687, 1528, 1475, 1213;  δH (400 MHz; CDCl3) 2.42 (3H, s, CH3), 3.71 (1H, dd, J 
11.0, 4.0, CHHI), 3.80 (1H, dd, J 11.0, 5.5 CHHI),  5.50 (1H, dd, J 5.5, 4.0, CH), 
7.59 (1H, dd, J 8.5, 4.5, ArH), 8.13 (1H, d, J 8.0, ArH), 8.42 (1H  , dd, J  8.5, 1.5 
ArH), 8.55 (1H, d, J 8.0, ArH), 8.84 (1H, dd, J 4.5, 1.5, ArH), 10.65 (1H, s, NH); 
δC (101 MHz; CDCl3) 3.3, 21.0,  73.0, 90.7,118.2, 123.4, 129.7, 134.1, 138.2, 139.2, 
140.8, 149.24, 165.7, 168.2;  m/z (ES) Found: MH+, 510.9014. C14H13N2O3I2 
requires MH+ 510.9016. 
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4.3.19 Acetoxy-N-Phthaloyl-L-alanine 8-aminoquinoline amide, 84 
 
 
The named compound was prepared by a minor modification of the 
literature procedure.54 A mixture of (S)-2-(1,3-dioxo-1,3-dihydroisoindol-2-
yl)-N-quinolin-8-yl-propionamide 50 (240 mg, 0.7 mmol), Pd(OAc)2 (31 mg, 
0.14 mmol), Mn(OAc)2 (144 mg, 0.83 mmol), Oxone® (2.14 g, 3.5 mmol) and 
Ac2O (0.7 mL, 7.0 mmol) in CH3NO2 (14 mL) was stirred at 80 °C under an air 
atmosphere. After 60 h the reaction mixture was filtered and washed with 
CH2Cl2 (2 x 15 mL). The solvent was removed under reduced pressure and 
the crude product purified by silica gel column chromatography (petrol-
EtOAc, gradient from 0-100% EtOAc) to give the product (142 mg, 52%) as a 
light-brown amorphous solid; m.p. 179-180 °C, lit. value 182-185 °C; [α]D20 
+8.9 (c 1.7, CHCl3), lit. value66 [α]D25 +8.2 (c 1.7, CHCl3); δH (400 MHz; CDCl3) 
2.21 (3H, s, CH3), 4.78 (1H, dd, J 11.5, 7.0, CHH), 5.15 (1H, dd, J 11.5, 7.5, 
CHH), 5.38 (1H, dd, J 7.5, 7.0, CH), 7.41 (1H, dd, J 8.5, 4.5, ArH), 7.49 (1H, d, J 
5.5, ArH), 7.50 (1H, d, J 1.5, ArH), 7.76 (2H, dd, J 5.5, 3.0 ArH), 7.90 (2H, dd, J 
5.5, 3.0, ArH), 8.13 (1H, dd, J 8.5, 1.5, ArH), 8.66 (1H, dd, J 4.5, 1.5, ArH), 8.68 
(1H, dd, J 5.5, 1.5, ArH), 10.52 (1H, s, NH). δC (101 MHz; CDCl3) 20.7, 52.9, 
61.8, 117.0, 121.6, 122.2, 123.8, 127.3, 127.9, 131.8, 133.8, 134.4, 136.4, 138.4, 
148.2, 164.4, 167.7, 170.2. Spectroscopic data is consistent with that 
previously reported.66 
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4.3.20 (1S)-2-(acetyloxy)-1-[(quinolin-8-yl)carbamoyl]ethyl acetate, 86 
 
 
(1S)-1-[(quinolin-8-yl)carbamoyl]ethyl acetate 78 (130 mg, 0.5 mmol), 
Pd(OAc)2 (13 mg, 0.058 mmol), PhI(OAc)2 (242 mg, 0.75 mmol), acetic 
anhydride (131 mg, 1.28 mmol) and o-dichlorobenzene (1.4 mL) were added 
to a 10 mL round bottom flask and stirred at 70 oC for 12 h. The o-
dichlorobenzene was removed by vacuum distillation and the crude product 
purified by silica gel column chromatography (20% EtOAc in toluene) to 
give the product (152 mg, 96%) as a cream amorphous solid; m.p 84-86 oC; 
[α]D20 +14 (c 1.0, CHCl3); νmax (film)/cm-1 3339, 2959, 2921, 1747, 1691, 1437, 
1488, 1232, 1210; δH (400 MHz; CDCl3) 2.08 (3H, s, CH3), 2.38 (3H, s, CH3), 
4.49 (1H, dd, J 12.0, 5.0 CH2), 4.73 (1H, dd, J 12.0, 3.0 CH2), 5.68 (1H, dd, J 5.0, 
3.0 CH), 7.50 (1H, d, J 8.5, 4.0, ArH), 7.58 (1H, d, J 3.0, ArH),  7.59 (1H, s, 
ArH), 8.21 (1H, dd, J 8.5, 1.5, ArH), 8.77 (1H, dd, J 5.5, 3.0, ArH), 8.85 (1H, dd, 
J 4.0, 1.5, ArH), 10.56 (1H, s, NH); δC (101 MHz; CDCl3) 20.6, 20.9, 63.1, 72.3, 
116.8, 121.8, 122.4, 127.3, 128.0, 133.4, 136.4, 138.6, 148.6, 165.2, 169.4, 170.6; 
m/z (ES) Found: MH+, 317.1128. C16H17N2O5 requires MH+ 317.1137. 
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4.3.21 (S)-(+)-tert-Butyl 2-(4-Methoxybenzyl)pyrrolidine-1-carboxylate 
 
 
Zinc dust (190 mg, 3 mmol) was added to a flame-dried, nitrogen-purged, 
round bottom flask. Dry DMF (0.7 mL) was added via syringe, followed by 
iodine (40 mg, 0.15 mmol); the yellow colour rapidly faded. Pd2dba3 (22 mg, 
0.025 mmol), SPhos (21 mg, 0.05 mmol), and 4-iodoanisole (468 mg, 2.0 
mmol) were added to the flask, and the reaction mixture was cooled in an ice 
bath. The iodide 9 (311 mg, 1 mmol) in DMF (0.8 mL) was added in 10 
portions, via syringe, over 5 h. The reaction mixture was allowed to warm to 
room temperature overnight. The crude product was purified using silica gel 
column chromatography (7% EtOAc in petroleum ether) to give the product 
as a colourless oil (159 mg, 55%); [α]D25 -2.1 (c 1.04, CHCl3), lit value [α]D25 -2.4 
(c 1.04, CHCl3);90 δH (400 MHz; CDCl3) 1.43 (9H, s, C(CH3)3), 1.55-1.81 (4H, m, 
2CH2), 2.54 (1H, dd, J 13.0, 9.0, CH), 2.88 (1H, dd, J 13.0, 3.5, CH), 3.11-3.19 
(1H, m, CH), 3.21-3.31 (1H, m, CH), 3.73 (3H, s, OMe), 3.81-3.90 (1H, m, CH), 
6.85 (2H, d, J 8.5, ArH), 7.07 (2H, d, J 8.5, ArH); δC (101 MHz; CDCl3) 22.1, 
28.6, 27.9, 45.8, 54.7, 57.9, 77.8,113.5, 129.7, 130.5, 153.1, 157.5, one peak 
obscured. Spectroscopic data is consistent with that previously reported.90 
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4.3.22 (2R)-2-(1,3-dioxo-2,3-dihydro-1H-isoindol-2-yl)-3-iodopropanoate, 90 
 
 
A solution of (R)-2-(1,3-Dioxo-1,3-dihydroisoindol-2-yl)-3-iodo-N-quinolin-8-
yl-propion-amide 53 (140 mg, 0.3 mmol) was refluxed in MeOH (3 mL, 1.25 
M) for 24 h. The solvent was removed under vacuum and the crude product 
purified using silica gel chromatography (20% EtOAc in petrol) to give a 
white solid; m.p. 81-83 oC, lit. value 82-84 °C;73 [α]D25 -37.0 (c 1.0, CHCl3), lit. 
value [α]D20 -39.5 (c 1.0, CHCl3);73 H (400 MHz; CDCl3) 3.80 (3H, s, OCH3), 
3.93-4.00 (2H, m, CH2), 5.10 (1H, dd, J 11.5, 5.0, CH), 7.83 (2H, dd, J 5.5, 3.0, 
ArH), 7.92 (2H, dd, J 5.5, 3.0, ArH); C (101 MHz; CDCl3) 0.3, 53.3, 54.0, 123.9, 
131.7, 134.5, 166.8, 167.2; Found: MH+, 358.9739. C12H10NO4I requires MH+ 
358.9733. Spectroscopic data is consistent with that previously reported.73 
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4.3.23 2-[(3S)-2-oxo-1-(quinolin-8-yl)azetidin-3-yl]-2,3-dihydro-1H-
isoindole-1,3-dione, 99 
 
 
(R)-2-(1,3-Dioxo-1,3-dihydroisoindol-2-yl)-3-iodo-N-quinolin-8-yl-propion-
amide 53 (236 mg, 0.5 mmol) and K2CO3 (75 mg, 0.55 mmol) were added to a 
solution of 0.5% H2O in DMF (5 mL) and stirred at rt for 6 hours. The 
reaction mixture was then diluted with brine (100 mL), extracted with EtOAc 
(3 x 50 mL) and dried over MgSO4. The solvent was removed under reduced 
pressure and the crude material purified using silica gel column 
chromatography to give the product as a amorphous white solid (140 mg, 
82%), (98% ee.); m.p. 163-165 °C; [α]D20 -26 (c 1.0, CHCl3); νmax (film)/cm-1  
3218, 2965, 2924, 1749, 1712, 1475, 1391, 830, 718; δH (400 MHz; CDCl3) 4.76 
(1H, dd, J 7.5, 3.0, CH2), 5.09 (1H, dd, J 7.5, 6.0 CH2),  5.71 (1H, dd, J 6.0, 3.0, 
CH), 7.42 (1H, dd, J 8.5, 4.0, ArH), 7.57 (1H, dd, J 8.0, 8.0 ArH), 7.62 (1H, dd, J 
8.0, 1.5 ArH), 7.77 (2H, dd, J 5.5, 3.0, ArH ), 7.90 (2H, dd, J 5.5, 3.0, ArH), 8.16 
(1H, dd, J 8.5, 1.5, ArH), 8.55 (1H, dd, J 8.0, 1.5, ArH), 8.83 (1H, dd, J 4.0, 1.5, 
ArH); δC (101 MHz; CDCl3) 52.0, 55.0, 117.0, 120.1, 121.4, 123.7, 123.9, 126.8, 
128.9, 131.8, 134.4, 136.0, 140.4, 148.8, 164.2, 167.0; m/z (ES) Found: MH+, 
344.1044. C20H14N3O3 requires MH+ 344.1035; CSP-HPLC: Lux 3u cellulose-2 
(25% iPrOH in hexane, 1.0 mL/min) (R)-99 41.33 min, (S)-99 49.89 min. 
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4.3.24 methyl (2S)-2-(1,3-dioxo-2,3-dihydro-1H-isoindol-2-yl)-3-[(quinolin-
8-yl)amino]propanoate, 100 
 
 
A solution of 2-[(3S)-2-oxo-1-(quinolin-8-yl)azetidin-3-yl]-2,3-dihydro-1H-
isoindole-1,3-dione 99 (172 mg, 0.5 mmol) was refluxed in MeOH (6 mL, 1.25 
M) overnight. The solvent was removed under vacuum and the crude 
product purified using silica gel chromatography (10% EtOAc in toluene) to 
give a brown solid; m.p 56-58 oC; (148 mg, 79%); [α]D20 -40 (c 1.0, CHCl3); νmax 
(film)/cm-1 3361, 2915, 2846, 1743, 1715, 1519, 1385, 1260; δH (400 MHz; CDCl3) 
3.82 (3H, s, OCH3), 4.21 (1H, ddd, J 14.5, 7.5, 8.5, CH2), 4.32 (1H, ddd, J 14.5, 
6.5, 6.0, CH2), 5.32 (1H, dd, J 8.5, 6.0, CH), 6.53 (1H, dd, J 7.5, 6.5, NH), 6.86 
(1H, d, J 8.0, ArH), 7.09 (1H, d, J 8.0, ArH), 7.33 (1H, dd, J 8.5, 4.0), 7.41 (1H, 
dd, J 8.0, 8.0, ArH), 7.73 (2H, dd, J 5.5, 3.0, ArH), 7.83 (2H, dd, J 5.5, 3.0, ArH), 
8.04 (1H, dd, J 8.5, 1.5, ArH), 8.64 (1H, dd, J 4.0, 1.5, ArH); δC (101 MHz; 
CDCl3) 29.7, 50.7, 52.9, 105.3, 115.0, 121.4, 123.6, 128.7, 129.1, 131.8, 134.3, 
136.0, 143.5, 147.0, 167.6, 168.9; m/z (ES) Found: MH+, 376.1285. C21H17N3O4 
requires MH+ 376.1297. 
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